Effect of disulfide bond scrambling on protein stability, aggregation, and cytotoxicity by Dutta, Colina
Michigan Technological University 
Digital Commons @ Michigan Tech 
Dissertations, Master's Theses and Master's Reports 
2016 
Effect of disulfide bond scrambling on protein stability, 
aggregation, and cytotoxicity 
Colina Dutta 
Michigan Technological University, ctdutta@mtu.edu 
Copyright 2016 Colina Dutta 
Recommended Citation 
Dutta, Colina, "Effect of disulfide bond scrambling on protein stability, aggregation, and cytotoxicity", Open 
Access Dissertation, Michigan Technological University, 2016. 
https://digitalcommons.mtu.edu/etdr/129 
Follow this and additional works at: https://digitalcommons.mtu.edu/etdr 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons, and the Chemistry Commons 
 
 
 
 
EFFECT OF DISULFIDE BOND SCRAMBLING ON PROTEIN STABILITY, 
AGGREGATION, AND CYTOTOXICITY 
 
 
 
By 
Colina Dutta 
 
 
 
 
 
A DISSERTATION 
Submitted in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
In Chemistry 
 
MICHIGAN TECHNOLOGICAL UNIVERSITY 
2016 
 
©2016 Colina Dutta
  
 
This dissertation has been approved in partial fulfillment of the requirements for the 
Degree of DOCTOR OF PHILOSOPHY in Chemistry.  
 
Department of Chemistry 
  
   Dissertation Advisor:              Dr. Ashutosh Tiwari 
   
 Committee Member:              Dr. Haiying Liu 
 Committee Member:              Dr. Lanrong Bi 
 Committee Member:              Dr. Chandrashekhar Joshi 
        Department Chair:              Dr. Cary Chabalowski
  
 
This dissertation is dedicated to 
“My Mother
 iv 
 
Table of Contents 
 
Preface........................................................................................................................ viii 
Acknowledgements ...................................................................................................... ix 
Abstract ........................................................................................................................ xi 
Chapter 1. Introduction ................................................................................................. 1 
1.1 Proteins ................................................................................................................ 1 
1.2 Structure of Proteins ............................................................................................ 2 
1.3 The Protein Folding Problem .............................................................................. 5 
1.3.1 Energetics of Protein Folding ...................................................................... 6 
1.3.2 The Misfolded Scenario ................................................................................ 9 
1.4 Protein Aggregation .......................................................................................... 11 
1.4.1 Types of Aggregates.................................................................................... 13 
1.4.2 Protein Aggregation and Neurodegenerative Diseases ............................. 15 
1.5 The Model Proteins ........................................................................................... 19 
1.5.1 Human Insulin ............................................................................................ 20 
1.5.2 Lysozyme ..................................................................................................... 22 
1.5.3 Serum Albumin ........................................................................................... 23 
1.6 Aims of Research .............................................................................................. 25 
References ............................................................................................................... 28 
 v 
 
Chapter 2. Methods ..................................................................................................... 33 
2.1 Spectroscopy ..................................................................................................... 33 
2.1.1 Ultraviolet (UV)-Visible Spectroscopy ....................................................... 34 
2.1.2 Fluorescence Spectroscopy ........................................................................ 37 
2.1.3 Fourier-Transform Infrared Spectroscopy ................................................. 45 
2.2 Microscopy ........................................................................................................ 49 
2.2.1 Scanning Electron Microscopy ................................................................... 49 
2.2.2 Atomic Force Microscopy .......................................................................... 54 
2.3 Cell Based Assays ............................................................................................. 56 
2.4 Polyacrylamide Gel Electrophoresis ................................................................. 58 
2.5 Mass Assisted Laser Desorption/Ionization (Time-of-Flight) Mass 
Spectrometry ........................................................................................................... 62 
References ............................................................................................................... 65 
Chapter 3.  Preformed Seeds Modulate Native Insulin Aggregation Kinetics ........... 68 
Abstract ................................................................................................................... 68 
Introduction ............................................................................................................. 70 
Materials and Methods ............................................................................................ 74 
Results ..................................................................................................................... 78 
Discussion ............................................................................................................. 111 
 vi 
 
Conclusion ............................................................................................................. 121 
References ............................................................................................................. 122 
Chapter 4. Disulfide Bond Scrambling at Acidic pH Promotes Insulin Aggregate 
Toxicity ..................................................................................................................... 132 
Abstract ................................................................................................................. 133 
Introduction ........................................................................................................... 134 
Materials and Methods .......................................................................................... 138 
Results & Discussion ............................................................................................ 153 
Conclusion ............................................................................................................. 164 
References ............................................................................................................. 165 
Chapter 5. Protein aggregation in a crowded environment....................................... 173 
Abstract ................................................................................................................. 174 
Introduction ........................................................................................................... 175 
Materials and Methods .......................................................................................... 177 
Results & Discussion ............................................................................................ 180 
Conclusion ............................................................................................................. 189 
References ............................................................................................................. 190 
Chapter 6. Conclusion and Future Directions ........................................................... 193 
Appendix ................................................................................................................... 196 
 vii 
 
Permission for Figures 1.1, 1.2 and 2.12 ............................................................... 196 
Permission for Figure 1.3 ...................................................................................... 197 
Permission for Figure 1.4 ...................................................................................... 198 
Permission for Figure 1.5 ...................................................................................... 199 
Permission for Chapter 3 ....................................................................................... 200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
 
Preface 
Contents of Chapter 1, 2, and 6 are written by the author of this dissertation. Chapters 
3, 4 and 5 are edited and organized by the author based on previously published paper 
(Chapter 3) and a manuscript in preparation (Chapter 5), details of which are described 
below. 
Chapter 3 is based on a five-author article that was published in The Journal of Physical 
Chemistry 2015, 119:15089-99. The author of this dissertation performed majority of 
the experiments, analyzed the data and wrote the paper. Ms. Mu Yang performed the 
ANS and Bis-ANS fluorescence experiments and Dr. Fei Long and Dr. Reza 
Shahbazian-Yassar helped with AFM imaging and analysis, respectively. Dr. Ashutosh 
Tiwari is the corresponding author and he revised the manuscript.  
Chapter 4 is based on a two-author article that is ready to be submitted in Chemical 
Sciences (RSC Publications). The author of this dissertation performed all of the 
experiments, analyzed the data and wrote the paper. Dr. Ashutosh Tiwari will be the 
corresponding author and will revise the manuscript.  
Chapter 5 is a three-author article for which the manuscript is under preparation. The 
author of this dissertation performed majority of the experiments, analyzed all the data 
and wrote the paper. Ms. Rashmi Adhikari performed the electrophoresis experiments.  
Dr. Ashutosh Tiwari will be the corresponding author and will revise the manuscript.  
 
 
 ix 
 
Acknowledgements 
Pursuing doctoral study is a task that can never be possible without the help and support 
of so many people who have touched my life in their own ways. I am indebted to all! 
First and foremost, I would like to express my sincere gratitude towards my advisor 
Dr. Ashutosh Tiwari for his continuous support, inspiration, and motivation for my 
Ph.D. study and related research. His unflinching guidance and impeccable patience 
succored me all the way through writing my dissertation. 
Besides my advisor, I am thankful to the rest of my committee members: Dr. Haiying 
Liu, Dr. Lanrong Bi and Dr. Chandrashekhar Joshi for their precious time, insightful 
comments and encouragement. 
I also owe my deepest gratitude towards Dr. Ravindra Pandey, without whom my Ph.D. 
journey would not have been possible. I am also thankful to Dr. Ranjit Pati for his 
encouragement, suggestions and support both on personal and professional front.  
I would like to convey my sincere thanks to our former and current Department Chair 
Dr.Sarah Green and Dr. Cary Chabalowski, respectively.  I am also grateful to the 
Department of Chemistry for the continuous funding support that made my journey 
easier and less stressful. Million thanks to Celine Grace, Denise Laux, Charlene Page 
and Margaret Dunsten for their assistance with a smile! 
I would also like to thank my colleagues Dr. Jagadeesh Janjanam, Nethaniah Dorh, Mu 
Yang and Rashmi Adhikari for all the scientific and non-scientific discussions and for 
being there. Special thanks to Nethaniah for being extremely supportive during 
 x 
 
desperate times. I can’t thank Jagadeesh enough for patiently teaching me everything I 
wanted to learn. He has been a continuous support as a postdoctoral researcher and a 
friend in the Tiwari Lab and even after that.  
Teaching has been an integral part of my graduate studies. I would like to thank my 
teaching supervisors Sarah Hill, Laleh Vahdat, Aparna Pandey, Kelley Smith, and 
Lorry Reilly, who taught me the ‘art of teaching’. 
I would also like to thank some very special friends (Neil (Rahul) Bose, Noopur 
Sharma, and Yogita Uplane) for their unique contributions towards my journey. 
I am deeply indebted to my parents and my in-laws for their love and faith in me. 
Last, but not the least, I owe everything to my husband Partha, without whom I could 
not have reached here. His immense faith, sacrifice, dedication and encouragement 
towards me, helped me sail through my doctoral studies. 
 
 
 
 
 
 
 
 
 xi 
 
Abstract 
Proteins are nano-machines that carry out majority of the cellular functions. 
Thermodynamically they are functional and stable within a very narrow range (1 
kcal/mol). External perturbations in the form of pH change, thermal, or 
oxidative/reducing stress can destabilize the protein resulting in misfolding and 
aggregation. Prolonged environmental stress can affect the cells adaptive response 
resulting in loss of ability to refold or recycle proteins. This can lead to accumulation 
of misfolded or aggregated proteins within the cell. Such accumulation of aggregated 
proteins have been associated with neurodegenerative disorders such as Amyotrophic 
Lateral Sclerosis (ALS), Parkinson’s, Huntington’s, and Alzheimer’s disease. There is 
a general consensus among scientists that aggregated proteins cause disease by a ‘toxic 
gain of function’. However, there is a huge debate among scientists on what are the 
toxic forms of protein aggregates. This is largely due to lack of research that have 
looked at the relationship between morphology of aggregates and their toxicity. 
Therefore, such studies that can help clarify the relationship between morphologically 
different forms of aggregates and their associated toxicity are needed.  
In this dissertation, we study how disulfide reducing environment can impact protein 
stability, aggregation, and cytotoxicity. We also study effect of molecular crowding 
agent polyethylene glycol (PEG) (600 and 2000 g/mol) on providing protection against 
reducing and thermal stress. Disulfide bonds are covalent interactions that provide 
major stability to the protein in conjunction with several non-covalent interactions such 
as hydrophobic interactions, hydrogen bonding, Van der Waal and electrostatic 
 xii 
 
interactions. These interactions help the proteins to fold into its native three-
dimensional fold. However, the cytoplasmic environment in cells is highly reducing 
and can compromise the disulfide bonds leading to protein aggregation. To better 
understand how disulfide bond scrambling can affect protein aggregation, we used 
insulin as a model protein. We made seeds of insulin by incubating the protein in 
presence of disulfide reducing agent for varying lengths of time at 37 °C. These seeds 
were labeled as ‘nascent’, ‘intermediate’, or ‘mature’ based on their ability to induce 
and promote aggregation of native protein with different kinetics. Nascent seeds 
promoted fastest insulin aggregation and formed amorphous aggregates. In another 
related study we used a combination of pH (acidic to basic) and temperature (37 and 
65 °C) to generate morphologically different types of insulin aggregates under disulfide 
reducing/non-reducing conditions. These aggregates were characterized by different 
techniques and tested for their toxicity on SH-SY5Y cells. Cytotoxicity studies of 
insulin aggregates on neuroblastoma cells showed that aggregates formed from 
disulfide reduced proteins at acidic pH were more toxic compared to the aggregates 
formed at neutral or basic pH. Lastly, we wanted to study how these properties could 
be impacted by molecular crowding. We mimicked the intracellular crowded milieu in 
vitro by using PEG to investigate the effect of crowding on lysozyme stability and 
aggregation under thermal and reducing stress. We observed that PEG-2000 stabilized 
the molten globule intermediate of lysozyme in the presence of a non-thiol based 
reducing agent. Overall, the results indicates an intricate relationship of pH, 
temperature, and reducing environment impacting proteins aggregation and its 
associated toxicity.
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Chapter 1. Introduction 
 1.1 Proteins  
Proteins form the center of any biological process. They essentially are the building 
blocks of life that are composed mainly of 20 standard amino acids. The sequence of 
amino acid in a protein, encodes for its function; that in turn dictates its interaction 
with other biological molecules. The function of proteins range from maintaining cell 
shape (structural proteins) to catalyzing biochemical reactions within the cell 
(enzymes).   Proteins also function as hormones that act as chemical messengers and 
direct processes within the living system.  
The amino acids within a protein, are covalently bonded together by the peptide 
bonds between the alpha carbon (Cα) atoms of amino (N-terminal) and carboxyl (C-
terminal) groups of adjacent amino acids. Linkage between amino acids occurs by a 
condensation reaction in which a water molecule is expelled leading to the formation 
of the peptide bond. Studies by Pauling and Corey revealed that the alpha carbon 
atoms in the peptide bond are separated by three covalent bonds Cα-C-N-Cα. X-ray 
diffraction studies revealed that the C-N bond in a co-planar peptide bond is slightly 
shorter than that present in an amine. This suggests the presence of a partial negative 
charge on oxygen and a positive charge on nitrogen. All these observations lead to 
the conclusion that the C-N bond within a peptide bond is rigid and free rotation is 
restricted due to partial double bond character. However, free rotation is possible 
around N-Cα and C-Cα bonds. The rigidity of the peptide bond in a protein provides 
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the structural basis in proteins and defines the secondary structure and tertiary fold in 
the protein. 
 1.2 Structure of Proteins 
The primary structure of a protein is formed by its amino acid sequence. Amino acids 
have a positively charged amino group and a negatively charged carboxyl group 
around neutral pH. They differ by the alkyl (R) group that can be broadly divided into 
hydrophobic and hydrophilic. Uncharged as well as aromatic alkyl groups are 
hydrophobic whereas charged ones are hydrophilic in nature. The folding of a protein 
is determined by the amino acid sequence since the hydrophobic residues form the 
core of the protein while the charged hydrophilic residues interact with the solvent in 
the cellular milieu. This ‘preference’ of interaction requires the protein backbone 
(peptide bond) to fold into the hydrophobic core, although it is highly polar and 
hydrophilic. This leads to the formation of secondary structures: α-helix and β-sheet 
that help in exposing the peptide bond to the solvent while the hydrophobic amino 
acids form the core of the folded protein.  
The α-helix is a common element of secondary structure in proteins and is 
predominantly right-handed (Figure 1.1). The helical structure forms in a way such 
that the N-H group of the nth residue of the protein is hydrogen bonded to the C=O 
group of the (n-4) residue. This ensures tight packing and Van der Waal contact 
throughout the helix. The alkyl groups point outward from the helix to minimize steric 
effects.  
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Figure 1.1 Right handed helix with the planes of the peptide bond parallel along the 
long axis of helix (shown as the rod)1. From: Lehninger Principles of Biochemistry 6E, 
by David L. Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and 
Company. Used by permission of the publisher. 
Another element of the secondary structure in protein is the β-sheet (Figure 1.2).  The 
protein backbone is fully extended in this pleated structure and hydrogen bonding exists 
between the NH and C=O groups of adjacent polypeptide chains. β-strands arrange 
themselves in two ways in order to form β-sheet, namely parallel and anti-parallel. 
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Hydrogen bonded polypeptide chains extend in the same and opposite directions for 
parallel and anti-parallel strands, respectively. Hydrogen bonding in parallel β-sheet is 
distorted, making it less stable compared to the anti-parallel arrangement.  
 
 
Figure 1.2. Top view of (A) antiparallel and (B) parallel β-sheet. R-groups extend out 
from the β-sheet (purple spheres) and hydrogen bonding between adjacent chains are 
shown as blue lines 1. From: Lehninger Principles of Biochemistry 6E, by David L. 
Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and Company. Used 
by permission of the publisher. 
The third category of secondary structure is called ‘turns’ or ‘loops’ that connect the α-
helix and β-sheets in a protein. These are flexible and irregular bends containing at least 
four amino acid residues hydrogen bonded to each other. 
The elements of secondary structure of a protein combine together to form the tertiary 
structure that is the three-dimensional folded protein. The tertiary structure ensures that 
amino acids that are far apart in the sequence interact with each other via weak 
interactions such as hydrogen bonding, electrostatic interactions and/or hydrophobic 
interactions. Additionally, covalent bond formation is also observed in the form of 
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disulfide bonds between cysteine residues. The native folding of the protein establishes 
a stable conformation with minimum free energy. The stable conformation of a folded 
protein is attained when the hydrophobic amino acids form the interior of the protein 
whereas the charged residues interact with the aqueous milieu. Another dimension of 
stability is added by the formation of disulfide bonds. These covalent bonds are formed 
by oxidation of sulfhydryl groups of cysteine residues and confer stability to the protein 
in a relatively hostile extracellular environment.  
Many proteins have multiple polypeptide chains (subunits) that interact with each other 
via hydrogen bonding, electrostatic interactions and/or disulfide bonds. The subunits 
associate themselves in a geometric arrangement and this spatial configuration forms 
the quaternary structure of the protein. Proteins with multiple subunits are prevalent 
mostly in metal binding proteins and enzymes. This provides a structural basis as a 
binding site for metal or receptors for proper functioning of the protein/enzyme. The 
quaternary structure of proteins forms the top of the protein-folding pyramid. 
1.3 The Protein Folding Problem 
Proteins need to fold into a three dimensional structure in order to function. The folding 
process was initially postulated to be a template driven process. However the limiting 
factor was the understanding as to how these “templates” formed. Anfinsen, in his 
experiment with Ribonuclease A, showed that the protein can be denatured and 
refolded and the process is reversible. In 1973, this became known as Anfinsen’s 
hypothesis that the amino acid sequence of a protein determines its three dimensional 
folding2. Although this hypothesis explained the thermodynamics of protein folding to 
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a great extent, the kinetics of protein folding was still unclear. In an attempt to 
understand the protein folding process, the folding pathways need to be elucidated. If 
proteins were to fold by randomly exploring all possible conformations, it would take 
approximately billions of years to fold. However, protein-folding process is in the order 
of microseconds. This inference, known as Levinthal paradox, lead to the hypothesis 
that protein folding is an ordered process in which the formation of the native fold is 
accompanied by the increase in conformational stability and decrease in free energy3.  
1.3.1 Energetics of Protein Folding 
The problem of protein folding is two-fold. The polypeptide chain needs to fold in its 
lowest energy conformation and also in doing so, must fold rapidly. Hence, the protein 
folding phenomena entails both thermodynamics and kinetics. The native state of the 
protein is favored by only 5-15 kcal/mol free energy. This means that the free energy 
of the native state of the protein is marginally lower than its denatured state. Protein 
folding is an entropically unfavorable process that is compensated by the decrease in 
enthalpy according to the second law of thermodynamics.  
∆𝐺𝐺 =  ∆𝐻𝐻 − 𝑇𝑇∆𝑆𝑆                                                                                                     (1.1) 
Van der Waal forces and electrostatic interactions stabilize the native fold and are 
unique for every protein. Proteins with conserved amino acid residues fold similarly, 
and it arises from the fact that interactions that stabilize a particular fold become 
destabilizing if the protein deviates from the native fold at physiological conditions. 
Hence the free energy of a folded protein is at a ‘deep’ energy minimum that is 
significantly distant from any destabilized protein folds. This gives rise to the classic 
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view that protein folding occurs via well-defined intermediates. Wolynes, Baldwin and 
Dill postulated the landscape theory4-6 where the energy surface of a folding protein is 
funnel shaped with the bottom of the funnel representing the native folded protein with 
minimum global free energy (Figure 1.35). The total binding energy required for a 
protein to fold is around 100 KBT, significantly larger than the barrier energy 
(approximately 10 KBT)5. Proteins fold into many native-like conformations that are 
close to the energy minimum before reaching the native fold. This is accounted for by 
the rugged topography of the funnel landscape of protein folding. Hence, a protein 
might also get trapped in a local minimum until it acquires the energy to overcome the 
barrier energy and continue the folding process.  
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Figure 1.3. Schematic of funnel-like landscape of protein folding. Native fold signifies 
lowest free energy5. 
The kinetics of protein folding has been explained by the advent of experimental 
techniques such as NMR, mass spectroscopy, and hydrogen exchange studies as well 
as statistical mechanics theoretical studies. The progression of protein folding is 
monitored using the variable – fraction of native contacts that goes from 0 in the case 
of unfolded protein to 1 for the native state. For an unfolded protein, the number of 
conformational ensembles is at a maximum that reduces throughout the folding process 
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and defines the shape of the folding funnel6. The normalized time taken (𝜏𝜏𝑓𝑓) for a 
protein to fold and reach the global minima in the funnel is given by  
𝜏𝜏𝑓𝑓 = ∫ 𝜏𝜏(𝑛𝑛)𝑑𝑑𝑛𝑛𝑛𝑛𝑓𝑓𝑛𝑛𝑢𝑢                                                                                                       (1.2) 
where the depth of the energy landscape funnel (n) varies from the unfolded state of 
the protein (𝑛𝑛𝑢𝑢) to the folded state (𝑛𝑛𝑓𝑓). 
1.3.2 The Misfolded Scenario 
The non-covalent interactions that stabilize protein structure are weak in nature. Hence 
marginal deviation beyond physiological conditions leads to protein instability. In the 
presence of destabilizing conditions such as removal of water and/or change in pH, 
temperature, salt concentration etc, can lead to the inter-conversion of the protein from 
its native state to unfolded state. The stability of a protein is expressed as the difference 
between the free energy between the unfolded (U) state and the native fold (N). 
𝑁𝑁 ⇌ 𝑈𝑈                                                                                                                      (1.3) 
The unfolded and native states have been studied experimentally using various 
spectroscopic and calorimetric techniques. It has been shown that native protein 
stability is not only due to the weak intermolecular interactions but also due to the 
protein-solvent interactions. However, experimental and theoretical studies have 
confirmed that protein structure is stabilized largely due to its hydrophobic interactions. 
Calculations using lysozyme have shown that hydrophobic and electrostatic 
interactions contribute 450 and 87 Kcal/mol respectively towards the free energy of 
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denaturation at room temperature7. These values are similar for globular proteins. At 
room temperature, hydrophobic free energy is mainly entropic that can be compensated 
by arranging the solvent molecule around the protein. Hence, hydrophobic interaction 
favors burial of the solvent exposed protein surface. 
Amidst all the favorable energy situations, the equilibrium of the protein towards the 
native state shifts towards unfolding due to stresses that lead to misfolding of the 
protein. Most globular proteins misfold by exposing the hydrophobic residues to the 
aqueous milieu. These processes are irreversible for most cases. This irreversible 
shifting of the equilibrium to the unfolded state leads to the hypothesis that misfolded 
proteins are also thermodynamically stable. Misfolded proteins come together in highly 
ordered forms to form protein aggregates. The aggregation pathway, stability of 
aggregates and associated energetics have been explained by the Lumry-Eyring 
framework as shown in scheme 1.4, where the native protein (N) undergoes reversible 
conformational change to form transition ensemble (TS*) that forms an intermediate 
(AI) after irreversible re-arrangement8. The misfolded intermediate AI associates with 
an aggregated protein molecule Am, thereby continuing the aggregation process.  
𝑁𝑁 ↔ 𝑇𝑇𝑆𝑆∗  ⟶  𝐴𝐴𝐼𝐼                                                                                                   (1.4a) 
𝐴𝐴𝐼𝐼 + 𝐴𝐴𝑚𝑚  ⟶  𝐴𝐴𝐼𝐼+𝑚𝑚                                                                                                (1.4b) 
This framework is true for all first order reactions and can be extended for bimolecular 
aggregation reactions as well. This stability of the aggregate form is attained by the 
interactions between the aggregated protein and the destabilizing factors that help in 
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stabilizing the aggregate form. This is explained using the free energy diagram in 
Figure 1.4 
 
Figure 1.4. Free energy diagram of the Lumry-Eyring framework explaining the 
energetics of protein aggregation and stability of aggregates. Kinetic energy barriers 
are shown using curved lines8. 
 
1.4 Protein Aggregation 
The process by which proteins unfold and associate themselves in clusters is called 
protein aggregation. The striking resemblance between different aggregated protein 
forms in spite of disparate amino acid residues suggests a common underlying 
mechanism of protein aggregation. This has led to the hypothesis of a generic 
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mechanism of protein aggregation. Destabilizing factors such as pH, temperature, 
solvent etc. disrupt the native interactions within the protein as well as between the 
protein and aqueous media. This exposes the hydrophobic amino acid residues leading 
to aggregate formation. This mechanism of protein aggregation is termed as off-
pathway. Depending on the pathway followed, distinct aggregate forms are generated. 
Energetically speaking, protein folding via the off-pathway route leads to aggregates 
with an altered global minima (Figure 1.5) 
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Figure 1.5. Energy landscape in case of protein folding and aggregation. Smooth 
funnel is shown in light grey whereas the ruggedness increases with the complexity of 
a protein leading to alternate folding forms (aggregates) shown in dark grey funnel9. 
1.4.1 Types of Aggregates 
Protein aggregates vary in morphology depending on the perturbation that leads to 
aggregation10. Highly ordered aggregate forms, known as amyloid fibrils, have been 
the focus of study for a long time due to their association with neurodegenerative 
Entropy 
En
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diseases such as Alzheimer’s and Parkinson’s disease11. Amyloid deposits are found 
within the brain and also major organs such as the liver and the spleen. These 
aggregates exhibit characteristic properties such as birefringence under plane polarized 
optical microscope, cross-beta X-ray diffraction pattern and tight binding with amyloid 
specific dyes such as thioflavin T12. Information gathered using these characterization 
methods reveal that amyloids are rich in β-sheet structure that runs perpendicular to the 
fibril axis13. Amyloid fibrils have been observed using many unrelated proteins14 and 
polymers suggesting a generic mechanism of aggregation15, although the propensity of 
fibril formation varies with proteins and is believed to be sequence-dependent16. The 
mechanism of fibril formation highlights the formation of intermediates and oligomers. 
They accelerate fibril growth both by nucleation-dependent and chain polymerization 
methods17. 
However apart from fibrils, other disordered aggregate forms (loosely termed as 
amorphous aggregates) have been found both in in vitro and in vivo studies18. These 
disordered aggregates have been broadly divided into particulates and spherulites19. 
Particulates20 are bead-like amorphous protein aggregates that have been found 
predominantly in β-lactoglobulin under thermal and pH stress21. This form of aggregate 
has not yet been associated with any medical relevance, however protein particulate 
formation is of great concern in the food industry.  When heated, the protein forms 
clear fibrillar gels away from its isoelectric point whereas at the isoelectric point, it 
forms particulates. These monodisperse particulates are a result of partial denaturation 
of β-lactoglobulin with average sizes varying between 1 to 1.5 μm. The size of these 
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particulates changes with heating rate and temperature. Rapidly heating the protein to 
100 oC results in smaller particulates with average size of 500 nm, whereas slow heating 
(1 oC/min) to 80 oC leads to bigger size distribution22. The mechanism of protein 
aggregation to form particulates has been elucidated in some studies. One model 
suggests that it is similar to a free radical polymerization method with initiation, 
propagation and termination steps. In this scenario, cysteine residues have been 
hypothesized to play the role of free radicals in disulfide-rich proteins. Another model 
explains protein particulate formation using nucleation and growth mechanism. 
Unfolded proteins form the nucleus that stimulates the formation of aggregates and 
increases the kinetics of aggregation. This method was used to explain the varying 
particle size of the particulates with respect to change in pH and temperature.  
Spherulites are another form of disordered aggregates that exhibit a characteristic 
maltese-cross pattern when viewed under the cross polarizers of an optical 
microscope23. These are radial arrangements of amyloid fibrils with a central core. 
However, the reason behind the equilibrium shift from amyloid fibrils to spherulites 
and its energetics is still unknown. Spherulitic growth has been observed in lysozyme, 
β-lactoglobulin, Aβ-42 and insulin among other proteins24. They also have been 
observed within amyloid plaques of Creutzfeld-Jacob disease, Down’s syndrome and 
rat model Alzheimer’s disease25.  
1.4.2 Protein Aggregation and Neurodegenerative Diseases 
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease, 
Amyotrophic Lateral Sclerosis (ALS) and other forms of dementia are a class of late 
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onset diseases that affect the central nervous system26. These diseases are characterized 
by the presence of abnormal proteinaceous deposits in the brain. Morphology of these 
deposits are predominantly fibrillar with characteristic properties common for all 
neurodegenerative diseases. These deposits are formed by misfolded and aggregated 
proteins. Proteins aggregate due to mutation in the sequence, genetic alteration of the 
protein or external stresses and aging. Protein folding in diseased condition has been 
proposed to be a cause of neurodegeneration, rather than an effect. This is supported 
by pathological and genetic information about the disease, animal model studies and 
also biophysical characterization of aggregated proteins in vitro27. 
The most common form of neurodegenerative disease is ALS. It was first described by 
French neurobiologist Jean-Martin Charcot in 1869 and was known as Charcot’s 
sclerosis until the 1930’s when baseball player Lou Gehrig was affected by this 
debilitating condition28. ALS is now familiarly known as Lou Gehrig’s disease.  The 
hallmarks of this fatal condition are progressive muscle weakness, spasticity, 
hyperreflexia, and atrophy due to degeneration of motor neurons in the brain and spinal 
cord29. 5-10% of this disease is linked to genetic mutations meaning that they are 
familial, however almost 90% is sporadic in nature.  
Mutations in the superoxide dismutase 1 (SOD1) protein contribute to about 20% of 
familial ALS cases. SOD1 is a 32 kDa homodimeric metallo-enzyme that is 
predominantly found in the cytosol30. Each subunit in the homodimer, form eight 
stranded Greek key β-barrel containing active sites for binding copper and zinc31. The 
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main function of SOD1 is free radical scavenging in the body, thereby preventing 
oxidative and mitochondrial damage to cells.  
Of the more than 153 SOD1 mutants that have been studied so far, most of them are 
missense mutations, with only a few C-terminal truncated forms32. As a part of the 
cells’ protein degradation system, misfolded proteins are targeted through 
ubiquitylation. These misfolded proteins have toxic effects on the proteosomal pathway 
and autophagy leading to the presence of ubiquitylated aggregates in patient brains33. 
The relationship between presence of misfolded SOD1 in the brain and occurrence of 
ALS is unknown. However, it is established that aggregated SOD1 confers a toxic gain-
of-function rather than a loss of normal function. This property is independent of the 
various SOD1 mutants that have been reported so far. The observations supporting this 
argument have been drawn from mice model studies34. However, SOD1 null mice did 
not develop the disease at all. Transgenic mice studies have been carried out for more 
than 100 mutations and all SOD1 mutant aggregates have been ubiquitin positive with 
presence of intracellular aggregates of the protein in motor neurons and astrocytes. 
Effects of SOD1 mutations are disparate where some mutants (G37R) do not lose 
normal activity. Additionally, no correlation has been found between activity of SOD1 
protein and the disease onset and progression. These lack of correlations make the 
scenario of understanding how SOD1 causes motor neuron death highly overwhelming.   
Apart from SOD1, several other proteins have been identified within the 
pathophysiology of ALS. Approximately 90% of sporadic ALS cases have been 
identified to be a result of mutations in the TARDBP gene35. This leads to aggregation 
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of TAR DNA binding protein (TDP-43) and is a major component of ubiquitinated 
inclusions in ALS patients. Aggregates of the wild type TDP-43 are also found in the 
motor neurons of the spinal cord, hippocampal neurons and glial cells of various motor 
neuron diseases. Hence, diseases linked to TDP-43 deposits have been termed as TDP-
43 proteinopathies.  
TDP-43 is a 43 kDa nuclear protein that binds to the RNA and DNA via its RNA 
recognition motifs (RRM). The entire protein has 2 RRMs, a nuclear localization 
sequence (NLS) and a glycine rich flexible C-terminal that mediates protein-protein 
interactions. The main function of TDP-43 is RNA splicing regulation and modulation 
of microRNA biogenesis32. It is also involved in cytoplasmic stress granule response 
and is a key component of dendritic RNA transport granules in neurons.  
Currently around 38 mutations in the TARDBP gene have been reported in ALS cases 
and most mutations are on the region encoding the C-terminal end of the protein36. In 
the diseased conditions, TDP-43 localizes to the cytoplasm from the nucleus 
accompanied by C-terminal degradation of the protein. Hyper-phosphorylated forms of 
the protein are a common hallmark of ALS, and the extent of disease progression is 
generally gauged by the spread of proteinaceous deposits from spinal and cortical 
neurons to other cortical regions37. However, the relationship between TDP-43 
proteinopathy and pathology is still unknown. A number of studies using animal 
models have confirmed that TDP-43 aggregation not only leads to toxic gain-of-
function (like SOD1), but also causes loss of normal function of the protein. While both 
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loss and gain plays a role in disease progress, the link between the two is yet to be 
established. 
1.5 The Model Proteins 
Protein folding is a complex process and the complexity increases when they misfold 
and aggregate. The main aim of studying the molecular mechanism of protein 
aggregation is to understand the disease process associated with these proteins for 
possible therapeutics. Owing to the complexity of disease-related proteins and the vast 
pool of unanswered questions, dissection of the molecular mechanism behind 
aggregation is very difficult. Therefore it is worthwhile to study the mechanism of 
aggregation in proteins that are well characterized, in order to provide a broader picture 
of the aggregation process. The motivation of studying model proteins and 
extrapolating the information to disease causing complex proteins is due to the generic 
mechanism of aggregation that is observed among unrelated proteins.  A large number 
of proteins such as carbonic anhydrase, myoglobin, β-lactoglobulin, lysozyme, bovine 
serum albumin (BSA), insulin etc. have been candidates for model protein. All these 
proteins aggregate under destabilizing conditions that can be controlled and the 
aggregation mechanism can be elucidated.   
We chose to study human insulin, lysozyme, and BSA as our model proteins due to 
their diversity in molecular weight, disulfide bond status and secondary structure. Also, 
all three proteins have a very high propensity to aggregate and two of these (insulin and 
lysozyme) have been linked to some form of amyloid diseases.  
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1.5.1 Human Insulin 
Insulin was discovered in 1920 by Dr. Frederick Banting, and is considered as one of 
the most important advances in the field. This protein played a pivotal role in advancing 
knowledge in peptide chemistry, structural biology and recombinant DNA technology. 
This 5.8 kDa hormone continues to be a subject of research owing to its use by insulin-
dependent diabetes patients and its aggregation propensity under various conditions in 
vivo and in vitro. Still today, insulin serves as a model protein for studying protein 
aggregation due to its small size, presence of highly conserved disulfide bonds and well 
defined secondary structure (Figure 1.6).  
 
 
 
 
 
 
 
Figure 1.6 Ribbon structure of human insulin hexamer. Figures generated using 
PyMOL 1.3 from PDB file 1AI0 
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Insulin is a 51 amino acid residue polypeptide with 2 chains A and B38. It is synthesized 
in the body as proinsulin (longer chain) and is cleaved off to release the active insulin. 
This messenger hormone is secreted by the pancreas into the blood where it binds to its 
receptor and helps in monitoring blood glucose in the body.  
Comparison of phylogenetic data and studies using various biophysical techniques 
show that the majority of amino acid residues are conserved in the insulin structure, 
across 100 vertebrates that were studied39. The conserved areas are those that bind to 
the insulin receptor for proper functioning of the protein, suggesting that the structure 
and function have been conserved throughout evolution. The structural features that 
have been conserved are the chain length, position as well as number of cysteine 
residues and 16 of the 51 amino acid residues.  
As with other eukaryotic organisms, insulin undergoes post-translational modifications 
that are required for its native fold as well as function. One of the important 
modifications is the formation of disulfide bonds that help maintain the stability and 
biological activity of insulin. This is ensured by the fact that insulin disulfides are 
thoroughly conserved between residues A6-A11, A7-B7 and A20-B19 as they hold the 
structure of the protein. The A chain forms a U-shape and sits on the B chain with 
hydrophobic interactions between 5 conserved leucine residues holding them together.  
The importance of each of the conserved disulfide bonds has been elucidated using 
protein-engineering methods. Substituting the cysteine in the A6-A11 bond leads to 
decreased binding affinity of insulin. This has been attributed to the loss of hydrophobic 
interaction in the A chain that majorly rests on the disulfide bridge between A6-A11. 
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Substitution of cysteine in A7-B7 has led to diverse outcomes. Studies have shown that 
these insulin analogs show substantially low biological activity, binding affinity and 
40% potency in mouse convulsion assay. Deletion or substitution of the C-terminal 
disulfide bridge A20-B19 has led to very poor expressions in yeast systems. Overall, 
the inter-chain disulfide residues help in maintaining the parallel orientation of chains 
A and B whereas the intra-chain disulfide bridge directs the folding of the protein by 
bringing the N and C terminal in close proximity that forms the insulin receptor binding 
site.  
1.5.2 Lysozyme 
Lysozyme was accidentally discovered by Dr. Alexander Fleming in 1921 during his 
search for medical antibiotics. It is a 14.3 kDa globular protein with 129 amino acid 
residues. The relatively small protein is abundantly found in tears and hen egg white. 
Lysozyme is a glycosidase enzyme that attacks the peptidoglycan cell wall of bacteria 
and hydrolyses them, thereby imparting anti-bacterial properties.  
This protein consists of two subunits, one predominantly α-helical and the other mainly 
β-sheet structure (Figure 1.7). The three-dimensional structure of lysozyme is stabilized 
by four disulfide bridges between C6-C127, C30-C115, C64-C80, and C76-C94. The 
disulfide bridge between C6-C127 keeps the N and C-terminal of the protein in close 
contact thus maintaining the protein stability and fold. Hence C6-C127 is partially 
solvent-exposed40. However, the other three disulfide bonds are buried within the 
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hydrophobic core of the protein. Lysozyme serves as a model protein, not only because 
it is well characterized but also because it has been linked with systemic amyloidosis.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Ribbon structure of hen egg-white lysozyme. Figures generated using 
PyMOL 1.3 from PDB file 1UCO. 
1.5.3 Serum Albumin 
Serum albumin is abundant in the circulatory system with a concentration of 35-50 
mg/mL in the blood plasma. It is a 66 kDa protein that transports various endogenous 
and exogenous compounds such as fatty acids, metals, amino acids, drugs etc. through 
the blood stream41. Transportation of various ligands occur by the binding of water-
insoluble molecules to the hydrophobic pocket of BSA. Apart from being a transport 
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protein, BSA also helps in maintaining blood pH and osmotic pressure. BSA is majorly 
α-helical with three homologous domains (I, II and III), 17 intra chain disulfide bridges 
and one free cysteine at position 35. Most of the disulfide bonds are buried within the 
core of this hydrophobic protein around neutral pH and the native fold is characterized 
by formation of nine disulfide loops. However, with increase in pH and temperature 
beyond physiological, some disulfide bridges become solvent accessible due to partial 
unfolding of the protein40.  
BSA maintains 76% homology with human serum albumin suggesting the importance 
of conserving the function of serum albumin protein. Serum albumin is considered a 
model protein due to its high molecular weight, high hydrophobicity and presence of 
large number of disulfide bonds that stabilize the structure of this globular protein.  
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Figure 1.8 Ribbon structure of bovine serum albumin. Figures generated using 
PyMOL 1.3 from PDB file 4F5S. 
1.6 Aims of Research 
Protein misfolding and aggregation have been linked to Alzheimer’s disease, 
Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS) and other forms of dementia 
that are neurodegenerative in nature. The molecular mechanism of these diseases needs 
to be investigated in order to continue the search for therapeutics. The main players 
identified in these diseases are SOD1, TDP-43, α-synuclein, and Aβ-42, among others. 
However, information on the structure and folding of these proteins are very limited. 
This makes understanding the aggregation process of these proteins and its relationship 
to diseases very complex.  
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Proteins aggregate due to various destabilizing effects, and one of the most crucial 
destabilizing factors is breakage of disulfide bonds. Disulfide bonds are covalent 
posttranslational modifications that predominantly have two functions. First, they 
influence the thermodynamics of protein folding by destabilizing and lowering the 
entropy of the unfolded protein and shifting the equilibrium to the native fold. Second, 
they maintain protein integrity, protect against proteolysis and increase shelf life of 
proteins. However, the reducing cytosolic environment or deviations in pH and 
temperature compromise the disulfide bonds that trigger protein aggregation.   
The main aim of this research is to understand the effects of reducing environment on 
the aggregation kinetics of the model protein insulin (Chapter 3). Understanding the 
aggregation of insulin in the presence of a reducing agent would be helpful since the 
protein is known to aggregate under storage conditions via disulfide bond scrambling. 
Insulin is also a disease related protein since it aggregates at the site of repeated 
injections in diabetes patients leading to injection amyloidosis. Aggregated insulin 
becomes the nucleus for further protein aggregation. We studied the kinetics of 
nucleation dependent insulin aggregation using preformed insulin seeds.  
Alternate forms of protein aggregation have been found within amyloid plaques in vivo, 
however their toxicity is still unknown. Diverse forms of protein aggregates have also 
been observed in in vitro studies using various proteins. The possibility of formation 
of alternate protein aggregates leads to the second aim of this research (Chapter 4). It 
is to characterize the morphology of different types of aggregates formed at diverse pH 
and temperature range, and correlate them to the cellular toxicity.  
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The aim of studying protein misfolding and aggregation is to understand the 
mechanism of protein aggregation and stabilize the native fold of the protein.  In the 
last part of this research, we study the effect of various macromolecular crowding 
agents on model protein - lysozyme aggregation (Chapter 5). These crowding agents 
are high molecular weight polymers that are known to protect the protein structure 
against aggregation and thus increase stability. We study the effect of these 
macromolecules on lysozyme aggregation under mild reducing as well as thermal 
stress, in order to investigate the protective role of these crowding agents against 
disulfide bond scrambling and aggregation. 
Insulin aggregation kinetics under various conditions was studied using UV/Visible 
Spectroscopy, Fluorescence Spectroscopy, Fourier-transform infrared spectroscopy 
(FTIR), Mass Spectrometry (MALDI-MS). Morphology of the aggregates and 
nucleation dependent insulin aggregation was investigated using Scanning Electron 
Microscopy and Atomic Force Microscopy. All techniques used to accomplish the aims 
of this research are discussed in Chapter 2 
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Chapter 2. Methods 
Biophysical and biochemical characterization of protein aggregation kinetics along 
with its morphology was carried out using various spectroscopic, spectrometric and 
microscopic techniques. Mass assisted laser desorption mass spectrometry (MALDI-
MS) and gel electrophoresis was used to analyze various species of protein aggregates 
present. Protein aggregation was monitored by measuring turbidity of protein solution 
at 600 nm using UV-visible spectroscopy. Protein unfolding, conformational change 
and exposure of hydrophobic pocket was monitored using intrinsic and extrinsic 
fluorescence. Secondary structure of protein aggregates were probed using Fourier 
transform infrared spectroscopy (FTIR). Morphology of protein aggregates was 
determined using scanning electron microscopy (SEM) and atomic force microscopy 
(AFM). The basic working principle of the techniques is discussed below. 
 2.1 Spectroscopy 
Spectroscopy entails the study of the interactions between electromagnetic waves and 
molecules. Electromagnetic waves are radiations with electrical and magnetic forces. 
Spectroscopic measurements involve the effects associated with the electrical effects 
of the electromagnetic spectrum.  The path of the electromagnetic wave is traced as a 
sinusoidal curve (Figure 2.1) where λ is the wavelength and A is the maximum 
amplitude of the wave.  
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Figure 2.1 Wave-like propagation of light. Light propagates in a sinusoidal path where 
one cycle is the distance between two troughs and the depth of a trough denotes the 
amplitude. 
 
The electromagnetic spectrum spans a vast energy range between 10-5 nm (cosmic rays) 
to 1014 nm (radio waves). Application of spectroscopy for studying proteins involves 
using radiation within the ultraviolet (200-380 nm), visible (380-780 nm) and infrared 
(780-3000 nm) regions1.   
2.1.1 Ultraviolet (UV)-Visible Spectroscopy 
 
UV-Visible spectroscopy is a form of absorbance spectroscopy that constitutes 
electromagnetic radiations from 200-780 nm (UV and visible). This form of 
spectroscopy assumes light as a stream of particles (photons) instead of waves. 
Molecules exist with discrete energy levels. Change in energy levels occurs in the 
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molecule by absorption of energy in the form of a photon. The energy (E) of a photon 
is defined as  
𝐸𝐸 = ℎ 𝑐𝑐
𝜆𝜆
                                                                                                                     (2.1) 
where h is the Planck’s constant, c is the speed of light and λ is the wavelength of 
energy used.  
The main principle of absorption spectroscopy is explained by Beer-Lambert’s Law.  It 
states that the fraction of incident monochromatic light that is absorbed by a molecule 
is proportional to the number of molecules in its path (Figure 2.2) 
 
 
 
 
 
Figure 2.2 Schematic representation of Beer-Lambert’s Law. Incident light (Io) is 
absorbed by a solution and transmitted light (I) leaves the solution. Concentration (C) 
of the solution is calculated using the path length l and extinction coefficient of the 
solute in the solvent. 
When light passes through a solution, the amount of light absorbed or transmitted is an 
exponential function of the concentration of solute in the solution2. Amount of light 
absorbed also depends on the length of the path of radiation through the solution. 
Mathematically, this can be explained as 
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log 𝐼𝐼𝑜𝑜
𝐼𝐼
=  𝜀𝜀𝜀𝜀𝜀𝜀                                                                                                              (2.1) 
Where 𝐼𝐼𝑜𝑜 is the intensity of the incident light, 𝐼𝐼 is the intensity of light transmitted 
through the solution, c is the concentration of solute in moles/L, 𝜀𝜀 is the path length of 
the sample in cm and ε is the molar absorptivity or molar extinction coefficient in M-
1cm-1. Molar extinction coefficient signifies how strongly a molecule absorbs light 
within a particular solvent at a specific wavelength. The logarithm of the ratio of the 
intensity of incident light to that of transmitted light is the absorbance (A) of the 
molecule. Hence, equation 2.1 can be rewritten at 
 A =  𝜀𝜀𝜀𝜀𝜀𝜀                                                                                                                   (2.2) 
Molar absorption coefficient plays a very important role in analyzing protein using UV-
Vis spectroscopy. Proteins absorb energy between 275 and 290 nm (Near-UV range 
because of the absorbance of aromatic residues Tryptophan (Trp), Tyrosine (Tyr), and 
Phenylalanine (Phe). Cysteine absorbs to a minor extent as well. Absorbance of 
aromatic residues depends on the environment and it is red-shifted when the 
environment changes from polar to non-polar. In the near-UV range, molar absorbance 
of Phe is significantly smaller than Trp and Tyr. Calculating the molar extinction 
coefficient from the amount of Trp, Tyr and Cys residues at a particular wavelength 
provide the basis of calculating protein concentration within aqueous media3. 
Absorbance of a molecule linearly depends on the concentration of the solute, making 
this technique suitable for quantitative measurements. The strength of absorbance not 
only depends on the chemical structure of the solute, but also on the environment 
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around the solute. Hence, this technique can be effectively used to measure protein 
concentrations and quantify protein aggregation. Protein aggregation can be quantified 
by measuring the absorbance of aggregates within the visible range at 350 or 600 nm 
(depending on the hydrodynamic radius of the aggregates). This is based on the 
increase in turbidity and absorbance of protein solution with increase in aggregated 
species.  
2.1.2 Fluorescence Spectroscopy 
 
Emission of light from substances occurs at their electronically excited states. This 
phenomenon is known as luminescence. Luminescence has two forms – fluorescence 
and phosphorescence, depending on the nature of excited state of the substance. In the 
case of fluorescence, the excited electron reaches a higher energy orbital with another 
electron of opposite spin in the ground state. This leads to return of the excited electron 
to ground state with emission of photon at a rate of approximately 108 s-1. Fluorescence 
is indicated in a Jablonski diagram (Figure 2.3) as a straight line going down along the 
energy axis between electronic states. Fluorescence is a relatively slow process hence 
most likely observed between the first excited state and the ground state of a molecule. 
Energy of photons emitted during fluorescence is equal to the energy difference 
between corresponding Eigen states, however the energy of the emitted photon is less 
than that of the excited photons due to energy lost in internal conversion. This 
difference of energy between absorption and emission is known as Stokes shift.  
The electronic states are depicted by So, S1, S2 etc where the molecules can exist in a 
number of vibrational energy levels depicted by Vo, V1, V2 etc. After absorbing light 
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in the form of a photon, molecules are excited to a higher energy level (S1, S2 or higher). 
The molecule relaxes instantly (in most cases) and reaches a lower vibrational energy 
level by a process called internal conversion, which precedes emission. Hence, 
emission occurs from a thermally equilibrated excited state4.  
 
 
Figure 2.3 Simplified Jablonski diagram showing the possible transitions during 
intrinsic fluorescence. Solid purple line shows absorption, followed by internal 
conversion, fluorescence (solid green line) and phosphorescence (solid red line). 
Adapted from Principles of Fluorescence Spectroscopy. Third Edition. Lakowicz, J.R. 
 
Molecules that exhibit fluorescence are known as fluorophores. Intrinsic fluorophores 
are those that exhibit fluorescence naturally. Intrinsic fluorescence is dominant in the 
aromatic residues of amino acids: mainly indole group of tryptophan, followed by 
tyrosine and phenylalanine to a lesser extent (Figure 2.4). This is because tryptophan 
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has the highest absorption coefficient (5.6 x 103 M-1cm-1) followed by tyrosine (1.4 x 
103 M-1cm-1) and phenylalanine (0.2 x 103 M-1cm-1). At 280 nm, only tryptophan and 
tyrosine absorbs and hence the observed fluorescence is contributed by both amino 
acids.  Unlike tyrosine, fluorescence of indole group of tryptophan residue may be blue-
shifted (shorter wavelength) when the residue is buried within the native protein, 
whereas red-shift is observed in an unfolded protein. This property is used to measure 
the kinetics of protein unfolding and aggregation. In a completely folded native protein, 
intrinsic fluorescence shows an increasing trend due to buried tryptophan residues. In 
an unfolded protein, tryptophan residues are exposed to the aqueous environment 
leading to fluorescence quenching.  
 
 
Figure 2.4 Structures of amino acid residues that exhibit intrinsic fluorescence. Figures 
generated using Chem3D Pro 12.0 
Extrinsic fluorophores are mostly covalently attached to proteins or ligands for 
fluorescence energy transfer and anisotropic measurements. However, a class of 
extrinsic fluorophores are those that interact with proteins and its degradation products 
via non-covalent interactions, mainly electrostatic and hydrophobic. These 
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commercially available fluorophores (dyes) are highly sensitive to the environment. 
These dyes have been extensively used in protein characterization to monitor protein 
folding and unfolding, to detect molten globule intermediates, to determine mechanism 
of aggregation and to assess surface hydrophobicity. Dyes used for protein 
characterization are tabulated in Table 2.1 and their structures are shown in Figure 2.5. 
Proteins are characterized using dyes in conjunction with steady state fluorescence 
spectroscopy. Light is absorbed by the dye that leads to excitation and transfer of 
electrons from the ground state (So) to higher singlet excited state. Excitation is 
followed by loss of energy by several processes, leading to Stokes shift. These 
processes are vibrational relaxation, internal conversion, solvent relaxation, and 
intermolecular charge transfer (ICT) or twisted intermolecular charge transfer (TICT). 
These electronic transitions are explained using a schematic in Figure 2.6. After the 
electron reaches the lowest vibrational energy level of S1 or S(T)ICT  in case of charge 
transfer process, the molecule relaxes to ground state by fluorescence emission or non-
radiative decay occurs. 
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Table 2.1. Extrinsic fluorescent dyes used for protein characterization and aggregation. 
Adapted from Hawe, A. et.al. (2007) Pharm.Res. 25(7): 1487-1499. 
Dye Application Stock 
Solution 
Extinction 
Coefficient 
(M-1cm-1) 
Excitation 
(nm) 
Emission 
(nm) 
ANS Surface 
hydrophobicity, 
protein 
folding/unfolding 
kinetics 
Ethanol, 
Aqueous 
5000 at 350 
nm in water 
350-380 475-505 
Bis-
ANS 
Surface 
hydrophobicity, 
protein 
folding/unfolding 
kinetics, 
conformational 
tightening 
Ethanol, 
Aqueous 
16790 at 
350 nm in 
water 
385-400 480-515 
ThT Aggregate 
morphology 
Ethanol 26620 at 
416 nm 
450 480-490 
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Figure 2.5 Structure of extrinsic fluorescent dye ANS, Bis-ANS and ThT, used for 
protein characterization aggregation studies. Structures made using Chem 3D Pro 12.0. 
 
These electronic transitions are accompanied by change in dipole moment of the dye. 
If the solvent also possesses a dipole moment, the solvent molecules reorient around 
the dye molecules to energetically favorable positions. This causes lowering of energy 
level S1 and energy level So rises, leading to increase in Stokes shift. This is known as 
solvent relaxation and depends on solvent polarity. Fluorescence properties of extrinsic 
dyes are also dependent on ICT and/or TICT. In both situations, an electron is 
transferred from a donor (amino group) to an acceptor (aromatic group) within the 
excited dye molecule. Both ICT and TICT induce charge separation causing an increase 
in dipole moment of the excited state S(T)ICT. T(ICT) is favored in polar solvents and 
relaxation occurs by solvent relaxation or non-radiative decay. This explains the weak 
fluorescence of dyes in polar solvents. Another factor that alters dye fluorescence is 
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hydrogen bonding. Solvents that are capable of hydrogen bonding shift the emission 
spectra of a dye significantly.  
 
 
Figure 2.6 Simplified Jablonski diagram showing the energy levels of the ground state 
and excited state, as well as electronic transitions in case of fluorescent dyes. 
Radiationless vibrational relaxation and internal conversion process (dashed arrows), 
solvent relaxation and TICT (dotted arrows) and fluorescence (solid arrows) are the 
possible outcomes when electrons absorb energy and reach excited state S1, S2 from 
ground state So. Adapted from Hawe, A. et al. (2007) Pharm.Res. 25(7): 1487-1499 
In the 1950s chemists found that introducing various substituted aniline groups in 
naphthalene derivatives, resulted in molecules like 1-anilinonaphthalene-8-sulfonate 
(ANS) and its dimeric analog 4,4’-bis-1-anilinonaphthalene-8-sulfonate (Bis-ANS). 
ANS and Bis-ANS fluorescence is sensitive to solvent polarity, viscosity and 
temperature. Blue shift and increase in quantum yield occurs with decreasing dielectric 
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constant of solvent (decrease in polarity). In the excited state, both dyes undergo TICT 
with charge transfer from amino-aryl group to sulfonated naphthalene group. 
Fluorescence properties of ANS and Bis-ANS depend on their interaction with protein 
molecules. Both dyes bind to proteins via hydrophobic and electrostatic interactions. 
Ion pairing between negatively charged sulfonate groups with positively charged amino 
acids (lysine, histidine, and arginine) is dominant in ANS-protein interaction. These 
ion pairs are stabilized by van der Waals interactions. In case of Bis-ANS, hydrophobic 
interaction is more dominant. While ANS is used to determine the exposure of 
hydrophobic residues in a protein molecule during the aggregation process, Bis-ANS 
fluorescence also depends on conformational tightening of the protein5. 
ANS and Bis-ANS are mainly used to monitor the mechanism of protein unfolding 
during aggregation and the conformation of the resultant aggregates respectively. 
Understanding the aggregation mechanism is accompanied by the question of 
aggregate morphology. Thioflavin T (ThT) is a classic dye used to understand whether 
protein aggregates are fibrillar structures or disordered amorphous forms. The dye 
binds to both aggregate forms with significant differences in the fluorescence intensity. 
When ThT binds to fibrils, fluorescence intensity is almost 10 times when compared to 
amorphous aggregate binding. Quantum yield of ThT is affected by solvent viscosity 
and rigidity of the microenvironment. The dye is almost non-fluorescent in solvents of 
low viscosity. This has been explained by the formation of a non-fluorescent TICT state 
accompanied by a change in the angle between benzothiazole and the benzene ring 
from 37o to 90o 5. 
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ThT was originally used as a histochemical stain for amyloid-like deposits in tissues. 
Later the application was extended for quantification of amyloid fibrils in vitro. 
Amyloid fibrils are highly ordered protein aggregates that are rich in β-sheet structures. 
In the presence of these filamentous structures, ThT exhibits absorption peak at 450 
nm and emits at 480 nm. The fluorescence is due to the formation of micelles binding 
to grooves of the fibrils. These grooves have a cavity size of less than 8 Å. Hence, 
amorphous aggregates with a similar cavity size also lead to fluorescence due to dye 
binding6. In bound form, ThT remains in flat conformation leading to increase in 
quantum yield due to inhibition of S(T)ICT state. 
2.1.3 Fourier-Transform Infrared Spectroscopy 
 
Infrared spectroscopy is a classical method for secondary structure determination of 
proteins due to its sensitivity to the chemical composition and architecture of 
molecules. Absorption of energy in the infrared region excites the vibrational 
transitions in a molecule. The vibrational frequency and probability of absorption 
depend on the polarity and strength of vibrating bonds, which is, related to the inter- 
and intra-molecular effects. The position of absorption band in infrared spectroscopy 
is determined by vibration masses, type of bonds involved, and position of electron 
accepting and electron donating groups. The strength of absorption increases with 
increase in polarity of the vibrating bonds. 
In 1950, Elliot et al.7 demonstrated that there is an empirical relationship between the 
vibrational frequencies of amide I and amide II absorptions of a protein and its 
secondary structure8, 9. Studies with proteins show that predominantly α-helical 
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proteins exhibit amide I and amide II spectral ranges of 1652 to 1657 cm-1 and 1545 to 
1551 cm-1 respectively, in aqueous medium. Proteins with β-sheet structures absorb 
between 1628-1635 cm-1 and 1521-1525 cm-1. Secondary structures such as turns, loops 
and random structures also absorb at specific wavenumbers. A list of wavenumbers and 
assignments to secondary structures in water is shown in Table 2.2. 
Miyazawa and co-workers later described the amide modes in the 1960s. It was 
elucidated that absorption in the amide I range was 80% due to C=O stretching in the 
amide group. The other 20% could be attributed to C-N stretching vibration. The amide 
II absorption arises from N-H bending and C-H stretching vibrations. The frequency of 
the amide I and II absorptions also depends on the strength of hydrogen bonds involved 
in amide C=O and N-H groups. Each amide group is associated with distinct secondary 
structures in a protein, due to its association with characteristic hydrogen bonding 
pattern between C=O and N-H groups. This forms the basis of distinct absorption bands 
for each secondary structure of proteins and is the main principle behind using infrared 
spectroscopy for secondary structure determination10, 11. 
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Table 2.2. Deconvoluted amide I band frequencies and assignments to secondary 
structure for protein in water. Adapted from Kong, J. et.al. Acta. Biochim.et. 
Biophys.Sin. (2007), 39(8): 549-559 
Mean frequencies in H2O Secondary Structure Assignment 
1624±1.0 β-sheet 
1627±2.0 β-sheet 
1633±2.0 β-sheet 
1638±2.0 β-sheet 
1642±1.0 β-sheet 
1648±2.0 Random 
1656±2.0 α-helix 
1663±3.0 310 Helix 
1667±1.0 β-turn 
1675±1.0 β-turn 
1680±2.0 β-turn 
1685±2.0 β-turn 
1691±2.0 β-sheet 
1696±2.0 β-sheet 
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Figure 2.7 Scheme of a Fourier transform infrared spectrometer. Adapted from Barth, 
A. Biochim.et.Biophys.Acta (2007), 1767: 1073-1101 
 
Modern infrared spectrometers are Fourier-transform infrared spectrometers (FTIR). 
The detector signal of the spectrometer is related by a Fourier transformation to the 
measured spectrum. The scheme of an FTIR spectrometer is shown in Figure 2.7. 
Quantification of protein secondary structure using FTIR is based on the assumption 
that any protein can be considered as a linear sum of individual secondary structure 
elements. The percentage of these elements is related to the spectral intensity. The 
simplicity of using FTIR to determine secondary structure of a protein is made complex 
by side-chain absorption. The contribution of side-chain in a typical globular protein is 
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roughly between 10-30% of the overall absorption. This is superimposed on the peptide 
absorption and might lead to changes in the amide I spectral band. Amino acid residues 
like lysine, arginine, histidine, asparagine, and glutamine absorb intensely in the amide 
I region. Hence it is important to quantify the amino acids in side-chains in order to 
refine the secondary structure determination of proteins8.  
2.2 Microscopy 
Proteins aggregate due to aberrant misfolding. Although the underlying mechanism of 
protein aggregation is similar, they form diverse aggregate forms. The pathophysiology 
of protein aggregation diseases is also dependent on the morphology of these 
aggregates that may influence their toxicity. The structure and morphology of these 
aggregates have been revealed by microscopy techniques such as scanning electron 
microscopy (SEM), transmission electron microscopy (TEM), and atomic force 
microscopy (AFM). 
2.2.1 Scanning Electron Microscopy 
 
Scanning Electron Microscopy (SEM) bombards a beam of high-energy electrons on a 
sample surface. The electron beam interacts with the solid sample and emit electrons 
from the sample. The type of electron emission is dependent on the interaction type and 
the depth of penetration of the incident electrons, as shown in Figure 2.8. As shown in 
the figure, emission of secondary and backscattered electrons is captured by the SEM 
detector. Secondary electrons are produced when an incident electron excites an 
electron in the sample and loses most of its energy in the process. The excited electron 
 50 
 
moves towards the surface of the sample undergoing elastic and inelastic collisions 
until it reaches the surface, where it can escape if it still has sufficient energy. 
Production of secondary electrons is very topography related and is used to understand 
sample morphology. Backscattered electrons consist of high-energy electrons 
originating in the electron beam that are reflected or back-scattered out of the specimen 
interaction volume. The production of backscattered electrons varies directly with the 
specimen's atomic number. These differing production rates cause higher atomic 
number elements to appear brighter than lower atomic number elements, revealing the 
composition of a specimen12. 
 
Figure 2.8 Interactions of incident electron beam with solid sample. Incident electron 
beam leads to emission of electrons from the sample depending on the interaction. 
Adapted from Scanning Electron Microscopy and X-ray Microanalysis. Third 
Edition Goldstein, J., Newbury, D.E., Joy, D.C., Lyman, C.E., Echlin, P., Lifshin, 
E., Sawyer, L., Michael, J.R. 
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The working of the microscope involve four basic steps (i) Stream of electrons is 
formed by the electron gun in vacuum, (ii) Electrons are accelerated towards the 
samples (with a positive electrical potential), (iii) Electrons are confined and focused 
using metal apertures and electromagnetic lenses into a thin monochromatic beam, and 
(iv) The sample is irradiated by the beam and the interactions are detected and 
transformed into an image. The converging of the electron beam after passing through 
various electromagnetic lenses is shown in Figure 2.9.  
While imaging biomolecules such a proteins using SEM, it is important that the sample 
does not degrade due to the heating effects associated with the high-energy electron 
bombardment. This necessitates the use of a cold field emission (FE) electron gun. The 
FE electron gun (cathode) is usually a wire of single-crystal tungsten fashioned into a 
sharp point and spot welded to a tungsten hairpin. The significance of the small tip 
radius, about 100 nm or less, is that an electric field can be concentrated to an extreme 
level. If the tip is held at negative 3-5 kV relative to the anode, the applied electric field 
at the tip is so strong that the potential barrier for electrons becomes narrow in width. 
This narrow barrier allows electrons to “tunnel” directly through the barrier and leave 
the cathode without requiring any thermal energy to lift them over the work function 
barrier.  
When nonconductive specimens such as biomolecules are directly illuminated with an 
electron beam, the electrons collect locally (specimen charge-up), thus preventing 
normal emission of secondary electrons. This charge-up causes some unusual 
phenomena such as abnormal contrast and image deformation and shift. Charging of 
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specimen is avoided by coating the sample with a conductive material such as platinum. 
The average coating thickness varies from 1 to 20 nm, depending on the stability of the 
sample. 
Both SEM and TEM are electron microscopy techniques in which electrons are 
bombarded on the sample to obtain morphological information. While TEM provides 
information in the nanometer range (100-200 nm), its use can be limited to more stable 
fibrils that do not disintegrate due to the high voltage used (100-200 kV). On the other 
hand, FESEM can be used to image relatively unstable biomolecules since it uses lower 
acceleration voltage (1-10 kV).  
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Figure 2.9 Schematic of the working principle of scanning electron microscope. 
Adapted from Scanning Electron Microscopy and X-ray Microanalysis. Third 
Edition Goldstein, J., Newbury, D.E., Joy, D.C., Lyman, C.E., Echlin, P., Lifshin, 
E., Sawyer, L., Michael, J.R. 
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2.2.2 Atomic Force Microscopy 
 
Atomic Force Microscopy (AFM) was invented by Binnig et.al. in 1986 and has been 
used since then to study molecular interactions, mechanical forces and surface 
topography11. It uses a force-sensing cantilever and has a very sharp tip that scans over 
the sample surface. As the distance between tip and surface decreases, the close-range 
attractive force between the surface and the tip causes the cantilever to deflect towards 
the sample. However, as the distance decreases significantly and the cantilever tip 
comes in contact with the sample surface, repulsive forces become dominant, causing 
the cantilever to deflect away from the sample. A typical schematic of AFM is shown 
in Figure 2.10.  
The tip of the cantilever scans through the sample surface and the tip-surface interaction 
is monitored by the deflection of the laser beam on the cantilever. This deflection is 
measured by a position sensitive quadrant photo diode and information is transferred 
to the computer. The tip rasters along x and y direction and the force between the 
surface and tip along z direction is measured as a function of x and y13.  
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Figure 2.10 Schematic drawing of AFM apparatus. The set up consists of a sharp tip 
integrated into the apex of a micro-fabricated cantilever spring, a solid substrate surface 
(piezo scanner) to support the sample, an optical beam apparatus to detect the 
cantilever’s deflection, and an electronic system to record and analyze data. Adapted 
from Barattin R. et al. (2008) Chem. Comm. 1513-1532 
 
AFM uses two modes to investigate the sample surface – contact mode and tapping 
mode. In contact mode, the tip remains in contact with the sample and is very sensitive 
even to the slightest of changes in the sample topography. Tapping mode is a dynamic 
mode where the tip oscillates close to its resonance frequency and scans the sample 
surface. The contact between the tip and surface during tapping results in the reduction 
of the cantilever vibration amplitude. In both contact and tapping mode, the deflections 
caused by the tip-sample interaction are measured by laser deflection13.  
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New generation AFM allows sample imaging under ambient conditions as well as 
within aqueous solutions at physiological conditions. This has greatly improved its 
usage for imaging biomolecules. Either contact or tapping mode can be used for 
biomolecular imaging with pros and cons for both.  Contact mode provides higher 
resolution images, although the sample needs to be immobilized on a surface in order 
to avoid deformation or damage. Immobilization can be a tedious process thereby 
limiting the use of contact mode. Tapping mode reduces sample deformation and 
damage, thus providing better accuracy14, 15.  
2.3 Cell Based Assays 
Cell based assays are mainly used to screen drug compounds by quantifying their effect 
on cell viability and proliferation. These assays are widely used to monitor organelle 
functioning and to measure receptor binding and signal transduction. In order to 
understand the mechanism of protein aggregation and the toxicity of aggregates with 
diverse morphology, it is important to study the effect of these aggregates on cells.  
A variety of cell based assays are available that measure an aspect of metabolism or 
enzymatic activity of viable cells. Dead cells are unable out carry to cellular function, 
and hence can be differentiated from live cells. These assays require incubating viable 
cells with a reagent that converts the substrate to a colored fluorescent product. The 
product is detected using a plate reader. The absorbance signal of the product at 490 
nm is roughly proportional to the amount of viable cells present14.  
Tetrazolium salt based reduction assays are most commonly used. Until recently, the 
most commonly used compound was (3-(4,5-dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide) (MTT). It is a positively charged compound that 
penetrates into viable cells. MTT was later developed into (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), which is a 
negatively charged compound that does not readily penetrate into cells. The mechanism 
of identifying viable cells using MTS reagent is shown in Figure 2.11. It involves an 
intermediate electron acceptor that can transfer electrons from the plasma membrane 
or cytoplasm, in order to facilitate the reduction of tetrazolium salt and formation of 
colored formazan product via mitochondrial succinate dehydrogenase enzyme16, 17. 
 
MTS reagent has an advantage over MTT because it is directly soluble in cell culture 
medium. This eliminates a liquid handling step of adding a second reagent to solubilize 
the formazan precipitates.  MTS reagent uses an intermediate electron acceptor such as 
phenazine methyl sulfate (PMS) or phenazine ethyl sulfate (PES) that can penetrate 
viable cells. These get reduced in the cytoplasm or cell surface and exit the cells where 
they are converted into soluble formazan products.  
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Figure 2.11 Reaction mechanism of MTS Assay. Intermediate electron acceptor 
phenazine ethyl sulfate (PES) transfers electron from NADH in the cytoplasm to reduce 
MTS in the culture medium into an aqueous soluble formazan.  
2.4 Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis (PAGE) is a versatile technique to separate 
macromolecules like proteins based on their molecular weight, conformation and net 
charge. The electrophoretic mobility of a protein is directly proportional to voltage and 
charge on the molecule and inversely proportional to the molecular weight, 
hydrodynamic radius, shape and size. A typical gel-electrophoresis set up is shown in 
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figure 2.12. Polyacrylamide gel is formed by the polymerization of acrylamide 
crosslinked by N,N’-methylene-bis-acrylamide (BIS). The polymerization reaction is 
initiated by ammonium persulfate (APS) and catalyst –N,N,N’N’-tetramethylene 
diamine (TEMED). The concentration of acrylamide and BIS can be varied to obtain a 
median pore size between 0.5 and 3 nm.  Additionally, anionic detergent sodium 
dodecyl sulfate (SDS) is also added. It denatures and binds to the protein and provides 
a uniform net negative charge to the protein. This allows separating proteins based only 
on their molecular weight and is known as SDS-PAGE. This type of electrophoresis 
also involves denaturing the protein by heating it in a buffer containing thiol-modifying 
agent 2-mercaptoethanol (β-ME). β-ME reduces the disulfide bonds in the protein to 
free sulfhydryl groups and SDS disrupts all the inter- and intra-molecular interactions.  
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Figure 2.12 A typical polyacrylamide gel electrophoresis apparatus set up. Protein 
samples are loaded in the wells and they migrate from cathode (-) to anode (+) on 
application of electric field1. From: Lehninger Principles of Biochemistry 6E, by David 
L. Nelson and Michael M. Cox, Copyright 2013, by W.H. Freeman and Company. 
Used by permission of the publisher. 
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A modification of SDS PAGE is a non-reducing SDS PAGE where already reduced 
disulfide bonds are prevented from re-forming by blocking the free sulfhydryls by 
iodoacetamide. After blocking, samples are mixed with buffer containing SDS sample 
buffer (without β-mercaptoethanol). This is important the protein already has reduced 
disulfide bonds and maintaining them is key for the investigation. 
In an alternate form of PAGE, SDS is not added and the protein is resolved on the gel 
based on its molecular weight as well hydrodynamic radius. This is known as Native 
PAGE since the protein samples are prepared in a non-reducing, non-denaturing buffer 
that helps in maintaining the secondary structure and shape of the protein. 
Typical gels used for protein separation are discontinuous gels. These are constructed 
with two difference acrylamide gels on top of one another. The upper gel (stacking gel) 
is a loose gel with 4-5% acrylamide content. The lower gel is resolving gel with a higher 
acrylamide content (8%-20%). Stacking and resolving gel are maintained at different 
pH and this discontinuity leads to a current discontinuity as voltage is applied. The 
combination of stacking and resolving gels increase the resolution of protein separation 
by concentrating the sample to an ultrathin zone at the boundary of stacking and 
resolving gel. The protein is mixed with running buffer that contains glycerol. High 
density of glycerol ensures that the samples remain within the “well” in the gel. The 
top of the apparatus forms the cathode whereas bottom forms the anode. When voltage 
is applied, proteins migrate downward to the positively charged electrode due the net 
negative charge on the protein (in case of SDS PAGE). In case of native PAGE, 
(protein’s net charge depends on content of acidic and basic amino acid) most proteins 
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that have isoelectric point (pI) in the 3-8 range migrate towards the positive electrode. 
If the protein of interest has a pI greater than 8, then native PAGE can be effectively 
performed by reversing the electrode polarity. The stacking gel has low ionic strength 
that increases the electrical resistance allowing the protein to migrate faster in the 
running gel18, 19.  
In all gels, a tracking dye called bromophenol blue (BPB) is used to determine the 
electrophoresis time where BPB serves as a visual indicator. BPB is a small molecule 
that migrates faster than the proteins and can be used effectively without losing proteins 
in the process.  
2.5 Mass Assisted Laser Desorption/Ionization (Time-of-Flight) Mass 
Spectrometry 
The main principle of mass spectrometry (MS) is to produce, separate and detect gas-
phase ions. Sample to be analyzed by this method needs to ionize to produce gas-phase 
ions. Traditionally, samples were ionized using electron impact or chemical ionization 
methods. However, these methods were not suitable for handling biomolecules since 
they fragment and degrade the molecules significantly during the ionization process. 
This called for development of ‘soft’ ionization techniques such as Mass Assisted Laser 
Desorption/Ionization (Time-of-Flight) Mass Spectrometry (MALDI-MS) for analysis 
of biomolecules20 as shown in figure 2.13 
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Figure 2.13 Typical set up of MALDI-TOF Mass Spectrometer. Analyte 
(biomolecules) is mixed with matrix and the co-crystals are allowed to form on the 
target and loaded into a vacuum chamber. Analyte molecules are desorbed by high 
energy radiation and accelerated through electric field causing the analyte ions to fly to 
the detector where the mass to charge ratio is obtained as the mass spectrum output. 
Adapted from Kim,S. et al. (2003) Nat. Rev. Genetics 4, 1001-1008. 
MALDI involves the use of a small crystalline organic compound (matrix) in which 
the sample of interest in embedded. The mix of sample and matrix is deposited on a 
conductive sample support (target). The matrix and sample co-crystals are irradiated 
with a nanosecond UV laser beam with a wavelength of 226 or 337 nm. This contributes 
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to an energy range between 1x107 and 5x107 W/cm2. This energy decomposes the co-
crystals and creates a particle cloud from which ions are extracted by an electric field. 
The ions in gas-phase are accelerated through the electric field followed by a drift in a 
field-free path and finally reaches the detector. This desorption process is mainly 
understood as the conversion of laser energy to vibrational collision energy of the 
crystal molecules, leading to disintegration of the crystal molecules. A variety of mass 
analyzers are available to study biomolecules such as proteins. These range from 
hybrid-quadrupole time-of-flight (Q-Q-ToF) and tandem time-of-flight (ToF-ToF). 
MALDI provides information in the form of mass to charge ratios (m/z) that is 
calculated by measuring the typical time-of-flight (TOF) through a tube of specified 
length in vacuum20-22. TOF is longer for larger molecules provided their initial energies 
are identical. MALDI predominantly generates single charged, non-fragmented ions, 
hence making data processing less complicated.  
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Abstract 
Insulin aggregates under storage conditions via disulfide interchange reaction. It is 
also known to form aggregates at the site of repeated injections in diabetes patients, 
leading to injection amyloidosis. This has fueled research in pharmaceutical and 
biotechnology industry as well as in academia to understand factors that modulate 
insulin stability and aggregation. The main aim of this study is to understand the 
factors that modulate aggregation propensity of insulin under storage conditions. 
We explored the aggregation kinetics of insulin at pH 7.2 and 37 °C in the presence 
of disulfide-reducing agent dithiothreitol (DTT), using spectroscopy (UV-visible, 
fluorescence, and Fourier transform infrared spectroscopy) and microscopy 
(scanning electron microscopy, atomic force microscopy) techniques. We prepared 
insulin ‘seeds’ by incubating disulfide-reduced insulin at pH 7.2 and 37 °C for 
varying lengths of time (10 min to 12 h). These seeds were added to the native 
protein and nucleation-dependent aggregation kinetics was measured. Aggregation 
kinetics was fastest in the presence of 10 min seeds suggesting they were nascent. 
Interestingly, intermediate seeds (30 min to 4 h incubation) resulted in formation 
of transient fibrils in 4 h that converted to amorphous aggregates upon longer 
incubation of 24 h. Overall, the results show that insulin under disulfide reducing 
conditions at pH and temperature close to physiological favors amorphous 
aggregate formation and seed ‘maturity’ plays an important role in nucleation 
dependent aggregation kinetics.
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Introduction 
More than 29 million people have diabetes in USA alone and this number is on the rise 
with more than one million new cases of diabetes diagnosed every year1. Nearly 14% 
of these patients take insulin, a globular hormone that has been used as treatment of 
insulin-dependent diabetes for more than seven decades1.  Studies in the last two 
decades show that insulin plays an important role in cognition and memory. Insulin is 
also known to regulate metabolism of beta-amyloid peptide and phosphorylation of tau-
protein that is robustly linked to Alzheimer’s disease2. Even though, insulin has been 
used for diabetes for several decades, its high cost due to poor stability and ease of 
forming aggregates when stored is a major challenge for the pharmaceutical industry. 
Insulin undergoes self-association by disulfide interchange reaction and aggregates 
under storage conditions3, 4. Previous works show that insulin tends to precipitate when 
reacted with a disulfide interchange enzyme in presence of reducing agent. This 
aggregation was attributed to scrambling of disulfide bonds5, 6. In addition, insulin can 
also aggregate at the site of injection in the subcutaneous tissue which has a pH of 
~7.27, 8. Even though, several insulin aggregation studies have been carried out at 
neutral pH either at high temperature or in the presence of chaotropic agents (e.g. urea 
or guanidine hydrochloride)9, 10, very few studies have explored insulin aggregation 
under conditions close to physiological11-13. Therefore, it is important to understand the 
factors that govern insulin stability and aggregation at neutral pH at which insulin is 
generally stored. Understanding the mechanism of insulin denaturation and aggregation 
during storage conditions will help in formulating effective solutions to increase the 
shelf life of the protein and prevent injection amyloidosis.  
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Insulin consists of two polypeptide chains: a 21-residue A-chain and a 30-residue B-
chain. It has 3 disulfide bridges that stabilize the protein structure; two inter-chain 
disulfide bonds (A7-B7, A20-B19) and one intra-A-chain (A6-A11) disulfide bond14,15. 
At acidic conditions, insulin is predominantly a monomer and the hexamer prevails at 
neutral pH16 (Figure 3.1). Insulin fibrils have been reported in case of human 
insulinoma as well as in pancreatic tumors17. Classically, the aggregation propensity of 
this protein has been studied at acidic pH and elevated temperatures18-21. Under these 
conditions, it has been shown to form fibrils that exhibit characteristic amyloid 
properties that are assumed to start from partially unfolded monomeric intermediates22, 
23. Changes in pH, ionic strength, anions, and stabilizers affect the lag time and fibril 
growth formation in insulin suggesting the importance of hydrophobic and electrostatic 
interactions during initial aggregation process13. Studies involving solvation effects on 
insulin fibrillation exhibited aggregation in the presence of ethanol and 
trifluoroethanol22. All these studies point towards a general hypothesis that any external 
perturbation contributes towards insulin aggregation18, 20, 23-27.  
 72 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Ribbon structure of insulin hexamer at neutral pH. Firebrick red sticks are 
used to denote the disulfide bonds (-S-S-) between A7-B7, A20-B19 and A6-A11 
positions in each monomer. The backbone is shown in gray color. The structures were 
generated using PyMOL 1.3 and PDB file 1AI029. 
 
Liquid insulin formulations prepared for diabetics, come with an expiration time span 
of 18-24 months. This long-term storage of insulin can lead to instability of the protein 
resulting in formation of unwanted products and possible complications such as 
injection amyloidosis when administered to patients14. One of the major causes of loss 
of native protein structure and aggregation is loss of critical S-S bonds or formation of 
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scrambled disulfide bonds that destabilize the protein structure 26, 27. Previous studies 
on insulin with reduced and alkylated disulfide bonds showed increased aggregation 
rate when compared to insulin with intact disulfide bonds27, 28. This underscores the 
importance of disulfide bonds in the overall stability and activity of the protein. 
Therefore, it is important to study how reducing environment near physiological pH 
can affect protein stability and hence modulate its aggregation over a period of time. In 
this study we show reduction of disulfide bonds of insulin leads to rapid aggregation 
within 10 min. Interestingly, we did not observe any fibrillar aggregates under these 
conditions. Instead, we observed amorphous insulin aggregates that stayed amorphous 
even after 6 months of incubation time. AFM images of native insulin in the presence 
of 30 min to 1 h insulin seeds show fibrillar aggregates after 4 h of incubation that 
converts to amorphous aggregates upon incubation for 24 h. Native insulin incubated 
with 10 min seeds form amorphous aggregates only. This study provides a mechanistic 
insight into insulin instability and how seeds from different stages of protein 
aggregation can affect native protein’s aggregation kinetics and the nature of 
aggregates. This may help us better understand nucleation dependent aggregation 
process at the molecular level for improperly stored insulin and injection amyloidosis 
in diabetes patients. 
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Materials and Methods 
Unless otherwise indicated, all materials were used as supplied by the manufacturer 
without any further purification. Human recombinant insulin, dithiothreitol (DTT), 
thioflavin T (ThT), 8-anilino-1-naphthalenesulfonic acid (ANS) dye, 4,4′-Dianilino-
1,1′-binaphthyl-5,5′- disulfonic acid (bis-ANS) dye were purchased from Sigma.  
Preparation of insulin samples - Insulin was dissolved in 0.025 M HCl at a 
concentration of 10 mg/mL. The protein was allowed to equilibrate overnight at 4 oC 
with mild agitation. To the insulin solution 0.025 M NaOH was added to neutralize the 
HCl. Then, insulin aliquots were made to the final concentration of 1 mg/mL (unless 
otherwise indicated) in 20 mM sodium phosphate buffer at pH 7.2 having 150 mM 
NaCl. All samples were prepared either in presence or absence of 10 mM dithiothreitol 
(DTT).  The samples were prepared on ice followed by incubation at 37 oC for the 
indicated time periods (see figures for details). Blanks (contained everything except 
protein) were similarly prepared and incubated as samples and were used for 
background subtraction.  
Seeding activity of disulfide-reduced insulin aggregates – Insulin seeds were prepared 
by incubating 1 mg/mL (172 µM) insulin in presence of 10 mM DTT in phosphate 
buffer, for 10 min, 30 min to 4 h (30 min intervals), and 4 h to 12 h ( 1 h intervals) at 
37oC. Post incubation, seeds were washed with distilled water using Millipore 
Amicon® Ultra centrifugal filters (3000 Da cutoff) and were added to freshly prepared 
native insulin sample (all disulfide bonds intact) at a concentration of 5%, 15% and 
45% v/v. Negative controls were prepared using identical conditions as samples but in 
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the absence of seeds. All samples were prepared on ice and then incubated at 37 oC for 
the indicated time. In addition to incubating insulin at 1 mg/mL (172 µM), samples 
were also diluted to a final protein concentration of 90 µM and 20 µM in phosphate 
buffer to study the effect of dilution on aggregation kinetics. All measurements were 
done in triplicates at 25 oC.  
Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry 
(MALDI-TOF MS) – Microflex LRF MALDI-TOF mass spectrometer (Bruker) 
equipped with microScout Ion Source was used to characterize disulfide states in the 
insulin samples. Insulin was incubated with 10 mM DTT for 0, 15 min, and 4 h at 37 
oC. Fresh native insulin was used as control. Post incubation, samples (and control) 
were incubated with freshly prepared 100 mM iodoacetamide (IAA) for 2 h at room 
temperature to block the free sulfhydryl groups. Low molecular weight contaminants 
were removed using C18 ZipTip®. Samples were prepared on the target using the direct 
droplet method. In this method, a saturated matrix solution of α-Cyano-4-
Hydroxycinnamic acid was mixed with solvent (0.1% trifluoroacetic acid (TFA) with 
33% acetonitrile (ACN)) having sample in 1:1 ratio v/v (matrix:solvent). From this 
mixture 1μL of sample was aliquoted and dried at room temperature on the target before 
analyzing.   
UV-visible absorbance spectroscopy- Absorbance measurements were performed 
using a Perkin Elmer Lambda 35 UV-visible Spectrophotometer. After completion of 
incubation, absorbance of samples was measured at 600 nm in order to assess turbidity 
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of insulin samples due to aggregation. All measurements were done at room 
temperature and in triplicates.  
Intrinsic and extrinsic fluorescence- Fluorescence measurements were carried out 
using a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4). Excitation and emission 
slit widths were set at 2 nm, each. For intrinsic fluorescence, emission spectra were 
acquired from 285 to 450 nm with excitation at 280 nm. For extrinsic fluorescence, 
emission spectra were acquired in presence of 10 µM ThT, 10 µM ANS, or 1 µM bis-
ANS. The concentrations of dye stocks were determined using their extinction 
coefficients: ANS ε350 nm = 5000 M-1 cm-1, bis-ANS ε385 nm = 16790 M-1 cm-1, and ThT 
ε416 nm = 26,620 M-1 cm-1. Protein samples were equilibrated with respective 
fluorophores on ice, in dark for 30 min before acquiring the spectra. For ThT 
fluorescence, emission spectra were collected from 460 to 650 nm with excitation at 
450 nm. Fluorescence spectra from 400 to 700 nm were collected with excitation at 
380 nm for ANS and at 360 nm for bis-ANS. All measurements were done in triplicates.  
Field Emission Scanning Electron Microscopy (FESEM) – Electron microscope 
images were collected using Hitachi S-4700 field-emission scanning electron 
microscope (FESEM). Samples incubated for indicated times were diluted with double-
distilled water and aliquoted in Millipore Amicon® Ultra centrifugal filters (3000 Da 
cut off). The diluted samples were centrifuged at 7000 x g at 4 oC (three repeats after 
dilution with water) to remove low molecular weight impurities (salt, buffer etc). The 
washed samples were aliquoted on SEM stubs and air-dried. The samples were 
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platinum coated using a sputter coater and imaged using an acceleration voltage of 10 
kV. 
Atomic Force Microscopy (AFM) – Aggregates of insulin were analyzed by aliquoting 
7 uL of sample on a freshly cleaved mica surface at 25 oC. AFM imaging was 
performed on Dimension ICON AFM system (Bruker, CA, USA) using Peakforce 
Tapping mode. Scan-Asyst-Air cantilevers (Bruker, CA, USA) with spring constant 
0.4 N/m and resonant frequency 70 kHz were selected as recommended by the 
manufacturer. AFM image analysis was carried out using NanoScope Analysis 
software from Bruker, CA, USA.  
Nano-mechanical measurements were performed using Dimension ICON AFM 
(Bruker, USA) under ambient conditions using Peakforce Tapping mode. RTESPA 
cantilevers (Bruker, USA) were selected with calibrated spring constant and tip radius 
of 55.6 N/m and 12 nm, respectively. For nano-mechanical measurements, 1 mg/mL 
insulin was incubated with 45% v/v seeds (10 min, 30 min, 1 h, 4 h) for 4 hours. 
Samples were prepared on freshly cleaved mica similar to AFM imaging. Derjaguin-
Mueller-Toporov (DMT) modulus analysis was carried out using NanoScope software 
from Bruker, CA, USA. The Young’s modulus value for each sample was calculated 
by averaging the moduli of each aggregate in a sample using the Nanoscope software. 
Fourier Transform-Infrared Spectroscopy (FT-IR) – Secondary structure 
determination of insulin seeds were performed using Perkin Elmer Frontier FT-IR 
spectrometer. Seeds were prepared by incubating 1 mg/mL insulin with 10 mM DTT 
at 37 oC for 10 min, 30 min, 1 h and 4 h followed by washing as discussed earlier. A 
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drop of sample was placed on the crystal and allowed to dry at room temperature.  Data 
was acquired at a resolution of 4 cm-1 and 128 scans were averaged per sample. Data 
was analyzed between 1800 and 1600 cm-1 after subtracting the background. Raw 
spectra were deconvoluted using Gaussian model to obtain the component peaks and 
the contribution from each peaks was calculated by integrating area under the curves 
using Origin 9.1. 
Results  
In this work, we monitored aggregation of insulin (Figure 3.1) in presence and absence 
of 10 mM DTT at pH 7.2 and at 37 oC. We also measured the aggregation kinetics of 
native insulin in presence of “seeds” prepared by incubating disulfide-reduced insulin 
(insulin incubated with 10 mM DTT) for different time periods (10 min to 12 h). The 
kinetics, morphology, and secondary structure of the aggregates were studied using a 
variety of biophysical and analytical methods.  Susceptibility of insulin to disulfide 
bond reduction was investigated using MALDI-TOF (Figure 3.2). Samples incubated 
for 15 min and 4 h with 10 mM DTT (Figure 3.2C, 3.2D) had the highest proportion of 
Insulin B-chain (3.5 kDa) along with dimers of full-length protein as well as B-chain 
(11.6 and 7.1 kDa respectively). Aggregated forms of B-chain dimer along with A-
chain were also observed at a molecular mass of 9.6 kDa. Trace amounts of A-chain 
(2.5 kDa) and insulin monomer were also visible. Fresh insulin in the absence or 
presence of reducing agent predominantly showed the existence of intact insulin 
(Figure 3.2A, 3.2B). However, in the presence of 10 mM DTT, the inter-chain disulfide 
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bonds in insulin were cleaved rapidly showing increase in B chain content (Figure 3.2C, 
3.2D). 
The extent of protein aggregation was monitored by measuring the turbidity (optical 
density (O.D.)) at 600 nm, using a UV-visible spectrophotometer (Figure 3.3). The 
absorbance of samples containing 10 mM DTT increased with increasing incubation 
time but was mostly unchanged for the control groups (proteins not treated with 
reducing agent). Significant increase in O.D. was observed within the first 1 h of 
incubation. 
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Figure 3.2 Mass spectrometry (MALDI-TOF) analysis showing effect of 10 mM DTT 
on disulfide status of insulin. Insulin was incubated with 10 mM DTT for 0 min, 15 
min, and 4 h at 37 °C. Fresh insulin was used as control. Post incubation, samples (and 
control) were alkylated with 100 mM IAA for 2 h before running on MALDI-TOF. 
Fresh insulin in the presence and absence of reducing agents were similarly alkylated 
using IAA and were run as controls.  
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Figure 3.3 Protein aggregation monitored by UV absorbance. Insulin was incubated at 
37o C for the indicated time periods and UV absorbance of the samples were measured 
at 600 nm. Error bars indicate ± SD. 
 
Insulin misfolding, conformational change, hydrophobic exposure, and aggregation 
were monitored by intrinsic and extrinsic fluorescence. Protein misfolding and 
conformational change for disulfide-reduced insulin was investigated by measuring the 
change in intrinsic fluorescence (Figure 3.4). We used extrinsic fluorophores such as 
8-anilino-1-naphthalenesulfonic acid (ANS), to measure misfolding and extent of 
hydrophobic exposure; and 4,4′-Dianilino-1,1′-binaphthyl-5,5′- disulfonic acid (bis-
ANS) as a conformational tightening agent and measure of hydrophobic exposure 
0 50 100 150 200 250 300 350
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Incubation Time (h)
O
.D
 60
0 
nm
Incubation Time (min)
 0 M DTT
 10 mM DTT
 82 
 
(Figure 3.5). Thioflavin T (ThT) was used to monitor the nature of aggregates (Figures 
3.8). The morphology (Figure 3.9 to 3.11, 3.21. 3.22) and secondary structure (Figure 
3.28) of the aggregates were further characterized by microscopy techniques (SEM, 
AFM) and FT-IR respectively.  
Insulin samples incubated with 10 mM DTT show a rapid decline in fluorescence as a 
function of time, whereas no measurable change in fluorescence intensity was observed 
for the protein in the control groups (0 M DTT). The steepest drop in fluorescence 
intensity for DTT treated samples is observed in the first 20 min (inset in Figure 3.4). 
Fluorescence intensity continues to decrease rapidly up to 48 h and then slows down 
and the intensity stabilizes. Misfolding and hydrophobic exposure of insulin was 
monitored using ANS and bis-ANS (Figure 3.5). Both ANS and bis-ANS show a rapid 
increase in fluorescence intensity in the first 20 min and then was steady beyond 1 h of 
incubation time. Control samples (samples with no DTT) did not show any change in 
fluorescence upon addition of the dyes.  
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Figure 3.4 Insulin unfolding monitored by intrinsic fluorescence. Fluorescence spectra 
for 172 μM insulin incubated with/without 10 mM DTT were collected from 285 to 
450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was selected. 
Peak fluorescence intensities are shown using open symbols (without DTT) and closed 
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error 
bars indicate ± SD. 
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Figure 3.5 Protein misfolding and hydrophobic exposure monitored by ANS and bis-
ANS fluorescence. Insulin samples at 172 μM concentration were incubated with 10 
µM ANS or 1 µM bis-ANS for 15 min before acquiring spectra. Emission spectra were 
collected from 400 to 700 nm with excitation at 380 nm for (A) ANS and 360 nm for 
(B) bis-ANS. Average peak emission wavelengths of 467 nm and 482 nm were selected 
for ANS and bis-ANS, respectively. Peak fluorescence intensities are shown using open 
symbols (without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for 
the first 1 h of incubation. Error bars indicate ± SD. 
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Figure 3.6 ANS fluorescence peak intensity and wavelength shift as a function of time.  
Insulin samples at 172 μM protein concentration were incubated with 10 μM ANS, and 
emission spectra were acquired as detailed in figure 4. Peak fluorescence intensities are 
shown in black and wavelength for peak maxima are in red. Error bars indicate ± SD. 
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Figure 3.7 ANS fluorescence emission spectra, peak intensity wavelength, and 
wavelength shifts as a function of time. Insulin samples at 172 μM protein 
concentration were incubated with 10 mM DTT and then were diluted with phosphate 
buffer (20 mM, pH 7.2) to a final concentration of 20 μM and 90 uM before analysis. 
Protein samples were incubated with 10 μM ANS and emission spectra was acquired 
for (A) 20 μM and (C) 90 μM insulin as detailed in figure 4. Wavelength shifts were 
plotted for (B) 20 μM and (D) 90 μM protein. Fluorescence intensities are shown in 
black and wavelength for peak maxima are in red. For emission spectra, peak 
fluorescence intensities are shown using open symbols (without DTT) and closed 
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error 
bars indicate ± SD. 
The nature and morphology of the aggregates were further characterized by ThT 
fluorescence, SEM and AFM imaging. ThT is known to bind to amyloid fibrils as well 
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as large aggregates and fluoresces30, 31. Fluorescence intensity for DTT treated insulin 
increased rapidly in the first 30 min of incubation, followed by a gradual increase upon 
longer incubation (Figure 3.8). Whereas, insulin incubated similarly but in absence of 
DTT (control groups) did not show any change in fluorescence intensity over the length 
of time. SEM images of insulin samples treated with DTT and incubated at 37 °C for 
different time periods (15 min, 2 h, 4 h, 168 h, or 6 months) were taken (Figures 3.9, 
3.10, and 3.11). Freshly incubated insulin samples with and without DTT were imaged 
as controls (Figure 3.10, panels A and B). All the aggregates were amorphous in nature 
with an average subunit diameter of 200 ± 100 nm (Figure 3.9)32. The morphology of 
aggregates remained unaltered even after a prolonged incubation of 6 months (Figure 
3.11). 
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Figure 3.8 Protein aggregation monitored by ThT fluorescence.  Emission spectra for 
57 μM insulin in the presence of 10 μM ThT were acquired from 460 to 650 nm with 
excitation at 450 nm. Average emission peak wavelength of 486 nm was selected. Peak 
fluorescence intensities are shown using open symbols (without DTT) and closed 
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error 
bars indicate ± SD. 
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Figure 3.9 Scanning electron microscope images of insulin aggregates. Aggregates of 
insulin were imaged using SEM. Insulin samples were incubated at 37 °C with 10 mM 
DTT for (A) 15 min, (B) 2 h, (C) 4 h, and (D) 168 h, respectively. Scale bar for all 
panels is 500 nm. 
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Figure 3.10 Scanning electron microscope images of insulin aggregates incubated for 
different times. Insulin aggregates were made by incubating 172 uM insulin in the 
absence (A) and presence (B-F) of 10 mM DTT at 37 oC, at pH 7.2. Insulin images are 
(A) 0 h (no DTT) and samples incubated with 10 mM DTT for (B) 0 h (C) 15 min (D) 
2 h, (E) 4 h and (F) 168 h, respectively. Scale bars are 50 μm, 10 μm, 5 μm and 500 nm 
from left to right. 
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Figure 3.11 Insulin samples incubated for 6 months show amorphous aggregates. 
Insulin was incubated at 37o C in presence of 10 mM DTT for 6 months before imaging 
the aggregates with SEM at indicated magnifications. Scale bars are shown in each 
panel. 
 
The effect of electrostatic interaction on insulin aggregation was studied in the absence 
as well as presence (150 or 300 mM) of NaCl. In addition, insulin concentration was 
also varied (20, 90, or 172 μM) (Figures 3.12 to 3.17). Increasing the salt concentration 
up to 300 mM did not alter the overall aggregation kinetics (Figures 3.12 to 3.17). 
Furthermore, change in insulin concentration (20, 90, or 172 μM) did not affect the 
overall trend for the fluorescence. 
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Figure 3.12 Effect of electrostatic interactions on insulin misfolding monitored by 
intrinsic fluorescence over time. Intrinsic fluorescence spectra were collected from 285 
to 450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was 
selected. Insulin samples at 172 μM protein concentration were incubated in the 
absence or presence of NaCl. Peak fluorescence intensities are shown using open 
symbols (without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for 
the first 1 h of incubation. Error bars indicate ± SD. 
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Figure 3.13 Effect of electrostatic interactions on insulin misfolding monitored by 
intrinsic fluorescence over time. Intrinsic fluorescence spectra were collected from 285 
to 450 nm with excitation at 280 nm. Peak emission wavelength of 306 nm was 
selected. Insulin samples at 172 μM protein concentration were incubated in the 
absence or presence of NaCl and spectra were acquired at a final concentration of (A) 
90 μM and (B) 20 μM. Peak fluorescence intensities are shown using open symbols 
(without DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for the first 
1 h of incubation. Error bars indicate ± SD. 
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Figure 3.14 Effect of electrostatic interactions on hydrophobic exposure monitored by 
Bis-ANS fluorescence over time. Fluorescence spectra were collected from 400 to 700 
nm with excitation at 360 nm. Peak emission wavelength of 482 nm was selected. 
Insulin samples at 172 μM protein concentration were incubated in the absence or 
presence of NaCl. Peak fluorescence intensities are shown using open symbols (without 
DTT) and closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of 
incubation. Error bars indicate ± SD. 
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Figure 3.15 Effect of electrostatic interactions on hydrophobic exposure monitored by 
Bis-ANS fluorescence over time. Fluorescence spectra were collected from 400 to 700 
nm with excitation at 360 nm. Peak emission wavelength of 482 nm was selected. 
Insulin samples at 172 μM protein concentration were incubated in the absence or 
presence of NaCl and spectra were acquired at a final concentration of (A) 90 μM and 
(B) 20 μM. Peak fluorescence intensities are shown using open symbols (without DTT) 
and closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of 
incubation. Error bars indicate ± SD. 
 96 
 
 
Figure 3.16 Effect of electrostatic interactions on insulin aggregation monitored by 
ThT fluorescence over time. Fluorescence spectra were collected from 460 to 650 nm 
with excitation at 450 nm. Peak emission wavelength of 486 nm was selected. Insulin 
samples at 172 μM protein concentration were incubated in the absence or presence of 
NaCl. Peak fluorescence intensities are shown using open symbols (without DTT) and 
closed symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. 
Error bars indicate ± SD. 
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Figure 3.17 Effect of electrostatic interactions on insulin aggregation monitored by 
ThT fluorescence over time. Fluorescence spectra were collected from 460 to 650 nm 
with excitation at 450 nm. Peak emission wavelength of 486 nm was selected. Insulin 
samples at 172 μM protein concentration were incubated in the absence or presence of 
NaCl and spectra were acquired at a final concentration of (A) 90 μM and (B) 20 μM. 
Peak fluorescence intensities are shown using open symbols (without DTT) and closed 
symbols (with 10 mM DTT). Inset shows a plot for the first 1 h of incubation. Error 
bars indicate ± SD. 
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Seeding experiments were carried out by incubating native insulin with seeds for 
varying lengths of time at 37 °C. Seeds were prepared by incubating disulfide-reduced 
insulin at pH 7.2 at 37 °C for 10 min, 30 min to 4 h (30 min intervals) and 5 h to 12 h 
(1 h intervals). Fresh insulin was incubated with 5%, 15% and 45% v/v of various seeds 
prepared. The kinetics and morphology of insulin aggregates in presence of seeds were 
analyzed by ThT fluorescence and AFM (Figures 3.18 to 3.27, Table 3.1). The 
aggregation kinetics of native insulin in the presence of seeds were calculated by fitting 
the ThT fluorescence data at 45% v/v seed concentration (Figure 3.23 to 3.25) till 4 h 
and the results are shown in Table 3.1.   Aggregation of native insulin was fastest in 
the presence of 10 min seeds (Figure 3.23, Table 3.1) followed by seeds incubated for 
30 min, 1, 1.5 and 4 h (Figure 3.24, Table 3.1). Seeds prepared by incubating insulin 
for longer time (5 to 12 h) showed a much slower aggregation kinetics (Figures 3.25, 
Table 3.1). Control samples (fresh insulin incubated without seeds) did not show any 
change over the experiment period of 7 days. Since, 10 min seeds showed fast and 
extreme aggregation efficiency, effect of seed concentrations at 5%, 15% and 45% v/v 
by ThT fluorescence on kinetics of native insulin aggregation was measured (Figure 
3.27). Seed concentrations alter the aggregation kinetics with 5% seeds showing a 
gradual but continuous increase in fluorescence, 15% seeds showing a rapid initial 
increase in fluorescence followed by gradual increase in fluorescence, and 45% seeds 
showing a very rapid increase in fluorescence intensity that peaks by 4 h of incubation 
time and then stabilizes. Insulin aggregates were prepared in the presence of seeds (10 
min, 30 min, 1 h and 4h) at a concentration of 45% v/v and were visualized using AFM 
with peak force tapping mode in air (Figures 3.21, 3.22). The elastic strength of the 
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aggregates along the radial direction (Young’s modulus) was measured using peak 
force QNM mode of AFM. This intrinsic stiffness of each aggregate in a sample was 
calculated using Nanoscope software and the average number was used to represent the 
Young’s moduli of aggregates generated using different timed seeds. The elastic 
strength of aggregates formed by incubating native insulin with different timed seeds 
(10 min, 30 min, 1 h, and 4 h) were comparable and ranged between 4 ± 0.6 and 6 ± 
0.2 GPa.  Aggregate population was maximum for protein incubated with 10 min seeds 
and it decreased with seed incubation time (Figure 3.21).  
Secondary structure of the protein seeds (10 min, 30 min, 1 h and 4 h) were analyzed 
using FT-IR (Figure 3.28) in the amide I band region (1700-1600 cm-1). The raw 
spectra were deconvoluted using Gaussian model to obtain the component peaks. 
Native insulin showed a peak at 1656 cm-1 whereas seeds exhibited peaks at 1656 cm-
1 and 1625 cm-1 upon deconvolution. Area under the peaks was integrated to obtain the 
relative contribution of component peaks at 1656 cm-1 and 1625 cm-1, respectively. 
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Figure 3.18 Effect of seeding (by different time seeds) on native protein aggregation 
monitored by ThT fluorescence. Seeding concentration used for all experiments was 
5% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or 4 
h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein 
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM 
concentrations. ThT fluorescence experiments were performed as detailed in Figure 
3.8. Error bars indicate ± SD.  
 
 
 
 101 
 
 
 
Figure 3.19 Effect of seeding (by different time seeds) on native protein aggregation 
monitored by ThT fluorescence. Seeding concentration used for all experiments was 
15% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or 
4 h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein 
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM 
concentrations. ThT fluorescence experiments were performed as detailed in Figure 
3.8. Error bars indicate ± SD. 
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Figure 3.20 Effect of seeding (by different time seeds) on native protein aggregation 
monitored by ThT fluorescence. Seeding concentration used for all experiments was 
45% seed v/v. Seeds were prepared by incubating 172 uM insulin for 10, 30 min, 1 or 
4 h, in presence of 10 mM DTT. The spectra were acquired at (A) 172 μM protein 
concentration and also after dilution of protein to (B) 90 μM and (C) 20 μM 
concentrations. ThT fluorescence experiments were performed as detailed in Figure 
3.8. Error bars indicate ± SD.  
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Figure 3.21 AFM Images of insulin aggregates after incubating with different timed 
seeds for 4 h.  Insulin samples at 172 μM protein concentration were incubated for 4 h 
in presence of seeds prepared by incubating for (A) 10 min (nascent seeds) (B) 30 min 
(intermediate seeds) (C) 1 h (intermediate seeds) and (D) 4 h (intermediate seeds). For 
panel A, B, C, and D the scale bar is 500 nm and the zoomed-in image in panel C is at 
100 nm. Arrows indicate proto-fibrillar structures. 
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Figure 3.22 AFM images of aggregated insulin after incubating with seeds for 24 h.  
Insulin samples at 172 μM protein concentration were incubated for 24 h in presence 
of seeds prepared by incubating disulfide-reduced insulin at pH 7.2 and 37 °C for (A) 
10 min (B) 30 min (C) 1 h and (D) 4 h. Scale bar is 500 nm.  
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Figure 3.23 Linear regression analysis of ThT fluorescence data. ThT fluorescence 
plots of native insulin aggregation in the presence of nascent seeds were fitted up to 4 
h and kinetics of aggregation was calculated using Origin 9.1 
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Figure 3.24 Linear regression analysis of ThT fluorescence data. ThT fluorescence 
plots of native insulin aggregation in the presence of intermediate seeds were fitted up 
to 4 h and kinetics of aggregation was calculated using Origin 9.1 
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Figure 3.25 Linear regression analysis of ThT fluorescence data. ThT fluorescence 
plots of native insulin aggregation in the presence of mature seeds were fitted up to 4 
h and kinetics of aggregation was calculated using Origin 9.1 
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Figure 3.26 Effect of seed incubation time on native insulin aggregation monitored by 
ThT fluorescence. Seeds were prepared by incubating 172 uM insulin for 10 min, 30 
min to 4 h (30 min intervals) and 4 h to 12 h (1 h intervals) in presence of 10 mM DTT. 
The spectra were acquired as detailed in Figure 3.8. Error bars indicate ± SD.  
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Table 3.1 Aggregation kinetics in the presence of seeds incubated from 10 min to 12h.  
 
 
 
 
 
 
 
 
 
 
 
 
Seed Incubation Time (h) Slope after Linear Fit (x103) 
0.2 235.92±4.86 
0.5 178.18±21.10 
1 214.29±29.52 
1.5 147.62±5.41 
2 84.68±11.65 
2.5 78.19±8.20 
3 131.11±39.12 
3.5 101.87±15.82 
4 161.77±41.66 
5 114.32±14.71 
6 89.17±22.77 
7 124.85±75.78 
8 35.82±6.06 
9 33.11±6.04 
10 146.00±42.22 
11 130.25±32.00 
12 98.37±25.46 
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Figure 3.27 Effect of seeding concentration of nascent seeds on aggregation kinetics. 
Nascent Seeds prepared by incubating insulin with 10 mM DTT for 10 min were used 
at a concentration of 5%, 15% and 45% v/v for seeding experiments. Protein 
aggregation was monitored by ThT fluorescence and was performed as detailed in 
Figure 3.8. 
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Figure 3.28 FT-IR Spectra for the amide I region of insulin aggregates. Aggregates 
were prepared by incubating 1 mg/mL insulin with 10 mM DTT for 10 min, 30 min, 1 
h and 4 h along with spectra of native protein. (A) Raw FT-IR spectra showing that 
amide bands are observed near 1656 and 1625 wavenumbers. (B) Raw FT-IR spectra 
(solid lines) and their component peaks (dotted lines) for the seeds. 
Discussion 
Insulin can easily aggregate due to destabilizing influences and the nature and 
morphology of these aggregates are diverse 11, 18, 19, 33-35. Under extremes of conditions 
such as pH, temperature, or denaturants, insulin forms beta-sheet rich fibrils 11, 36. 
Several other aggregation studies at physiological pH and temperature in combination 
with external perturbations show that proteins can misfold and form a range of 
aggregate forms 19, 22, 37. Both amyloid formation and amorphous aggregates have been 
reported in the disease process and have been shown to be dependent on external 
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factors. In addition, importance of conserved disulfide bond providing stability to 
proteins has been explored in several studies 38-40. It is known that insulin aggregates 
at storage conditions by a beta-elimination reaction (scrambled disulfide bonds) and 
this may lead to aggregation of insulin at the injection site of diabetes patients leading 
to injection amyloidosis. Therefore, to better understand the kinetics and mechanism 
of insulin aggregation with compromised disulfide bonds; we studied the effect of 
different preformed seeds on the aggregation kinetics of native insulin. In this work, 
we used DTT as disulfide reducing agent to accelerate the disulfide scrambling process.  
We measured the extent of disulfide reduction using MALDI-TOF mass spectrometry 
(Figure 3.2). Fresh insulin sample spectra showed that it was predominantly monomer 
(Figure 3.2A, 3.2B). Insulin incubated with 10 mM DTT for 15 min and 4 h show a 
significant increase in B-chain monomers (3.5 kDa) with appearance of a new peak at 
7.1 kDa that indicates B-chain dimers. Relative abundance peak for insulin monomer 
(5.8 kDa) decreased in presence of DTT when incubation time was increased from 15 
min to 4 h.  (Figure 3.2C, 3.2D). Appearance of a new peak was observed at 9.6 kDa 
for insulin incubated with DTT at 15 min and 4 h samples suggesting presence of 
aggregated forms of B-chain dimer with A-chain or presence of tetramer of A-chain. 
The data suggests cleavage of inter-chain disulfide bonds in insulin at positions A7-B7 
and A20-B19 leading to generation of insulin A and B chains. An increase in molecular 
weight of ~20-30 Da for the samples could be due to the residual buffer ions present as 
contaminants in the sample.  
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We monitored aggregation kinetics and secondary structure of insulin at pH 7.2, 37 oC 
using various spectroscopic techniques (Figures 3.3 to 3.8) and morphology of 
aggregates were characterized by SEM and AFM (Figures 3.9 to 3.11 and 3.21, 3.22).  
We investigated effect of 10 mM DTT on insulin instability and aggregation. As 
turbidity is a direct measure of the amount of aggregation, the optical density of the 
aggregated samples were measured at 600 nm. This method is very useful to detect 
aggregates with a hydrodynamic radius greater than the wavelength of light used24, 41. 
The aggregation propensity was highest in the first 20 min, after which the process 
slowed down considerably. Proteins that were incubated for shorter time periods 
showed a very sharp increase in absorbance within the first 10 min, implying rapid 
initial aggregation (inset in Figure 3.3). This suggests increased instability and 
unfolding of insulin in presences of DTT that leads to misfolding and aggregation of 
the protein within 10 min of incubation. Controls similarly incubated in the absence of 
DTT did not exhibit any turbidity or increase in absorbance. 
Insulin does not have any tryptophan residues therefore intrinsic fluorescence of insulin 
was measured by monitoring the exposure of tyrosine (Tyr) residues at 306 nm42,43. 
Decrease in fluorescence intensity at 306 nm (Figure 3.4) suggests exposure of Tyr 
residues to polar (aqueous) environment leading to fluorescence quenching as a 
consequence of protein unfolding44.  Fluorescence intensity decreases rapidly in first 
20 min followed by a gradual decrease up to 48 h, which is in line with the UV 
absorbance data. This suggests that insulin in presence of disulfide reducing agent 
unfolds rapidly exposing the hydrophobic core (aromatic residues) followed by 
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aggregation. This can be a direct result of catalytic amount of reducing agent promoting 
‘disulfide scrambling’ and drastically altering the protein stability21, 25, 26. The effect of 
10 mM DTT on protein misfolding and hydrophobic exposure was measured using 
fluorescent dye ANS and its dimeric analog bis-ANS. ANS is highly fluorescent and 
blue shifts (peak maximum shifts to 470 nm) upon binding to the hydrophobic core of 
the protein45. The dimeric analog of ANS, bis-ANS shares similar properties to ANS 
but has a higher binding affinity for molten globule like structures of proteins (Figure 
3.5). Both dyes exhibit similar trends with rapid increase in fluorescence intensity in 
the first h followed by high but steady fluorescence emission at longer incubation times. 
In presence of disulfide-reduced insulin at 172 µM concentration, ANS shows rapid 
increase in fluorescence in the first few min of incubation that peaks and then steadies 
in 1 h (Figure 3.5A). The peak wavelength for ANS stays steady at ~470 nm for the 
length of incubation (Figure 3.6). The disulfide reduced insulin at 90 and 20 µM also 
showed emission spectra similar to that seen for 172 µM protein (Figure 3.7A, 3.7C). 
Interestingly, at these lower protein concentrations the peak wavelength for ANS that 
is initially around 500 nm shifts to ~470 nm in about 20 min and stays steady at ~ 470 
nm even upon longer incubation (Figure 3.7B, 3.7D). This suggests that disulfide 
reduced insulin unfolds and the hydrophobic amino acid residues that are initially 
solvent exposed collapse and aggregate burying the hydrophobic residues (Figure 3.7). 
At protein concentration of 172 µM the unfolded protein burden is very high and it 
rapidly undergoes hydrophobic collapse aggregating with peak wavelength observed 
at ~470 nm (Figure 3.6). Controls (proteins with intact disulfide bonds) did not show 
change in fluorescence as a function of time. This is in line with other protein 
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aggregation studies where exposure of hydrophobic amino acids is followed by 
collapse and burial of the hydrophobic core35, 46-48.  
ThT was used to investigate the nature of insulin aggregates. ThT showed very rapid 
increase in fluorescence in the first 1 h of incubation with disulfide reduced insulin 
followed by gradual increase in fluorescence for the rest of the length of incubation 
(Figure 3.8). This observed trend of fluorescence increase for ThT is similar to earlier 
protein aggregation studies suggesting amyloid formation 27, 49-51. The interaction 
between ThT molecules and amyloid β-sheets results in high fluorescent emission at 
480 nm45. However, some other studies have shown that ThT dye can also interact with 
large amorphous aggregates by stacking in between the aggregates, leading to increased 
fluorescence 52, 53. Therefore, ThT fluorescence alone cannot accurately provide 
structural information about protein aggregates and needs further independent 
verification. We used SEM to image the aggregates and visualize the morphology of 
these aggregates. Electron microscope images show that the aggregates are amorphous 
in nature (Figure 3.9 to 3.11) that stay amorphous even upon longer incubation (Figure 
3.11). Size of aggregates ranged between 100-200 nm, depending on the length of 
incubation (Figures 3.9 to 3.11)30. Comparing the aggregates formed during the first 15 
min (Figure 3.9A) with longer incubation time, the density of aggregates was seen to 
increase dramatically with time (Figure 3.10) but the nature of aggregates remained 
amorphous. As shown, large insulin aggregates were made of smaller units, suggesting 
a mechanism similar to ‘chain polymerization’ (Figure 3.10). This implies that 
unfolded insulin monomer comes together to form multimers that in turn join together 
to form macromolecular aggregates. SEM image of fresh insulin with DTT (control 
 116 
 
sample, Figure 3.10) shows very few aggregates that rapidly increases in size and 
number of aggregates in the first 15 min, after which the change is not as dramatic. 
This is in line with the observed data for unfolding, misfolding, and aggregation 
kinetics of insulin (Figures 3.3 to 3.8).  Studies by several groups have suggested that 
amorphous aggregates are precursors of amyloid fibrils31, 37, 54, 55. In order to test if 
disulfide-reduced insulin at physiological pH that is initially observed as amorphous 
aggregates turn into fibril; we imaged similarly incubated insulin (pH 7.2, 37 °C) 
samples after 6 months (Figure 3.11). We only observed amorphous aggregates even 
after such a long incubation time under the experimental conditions (Figure 3.11). 
These results are in line with other reports showing formation of amorphous aggregates 
even upon longer incubation31, 56, 57.  
Salt has been shown to accelerate protein aggregation58, 59. Effect of salt concentration 
was illustrated in the absence and presence of NaCl (150 or 300 mM) (Figures 3.12 to 
3.117). Aggregation kinetics showed trends that were similar for proteins with/without 
NaCl and the results were comparable to our earlier results (Figure 3.3 to 3.8), at all 
protein concentrations (Figures 3.12 to 3.17). This suggests that insulin aggregation 
under reducing conditions is independent of ionic strength at pH 7.2. These results are 
in line with another study where chaotropic role of NaCl was absent in the process of 
insulin aggregation, both at acidic and at neutral pH11.  
Insulin has been shown to aggregate at repeated injection sites of diabetic patients 
leading to a critical medical condition known as injection amyloidosis8. Many studies 
have shown that aggregation of proteins is propagated by a nucleation-dependent 
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polymerization method where a “nucleus” is formed by assembly of monomers. 
Although, this process is thermodynamically and kinetically unfavorable, it decreases 
the energy barrier for aggregation, reducing the lag time and shifting the equilibrium 
towards unfolded state of the protein24, 60. To understand how nucleation can impact 
aggregation of native insulin we prepared “seeds” by incubating insulin in the presence 
of 10 mM DTT for 10 min, 30 min to 4 h (30 min interval), and 5 h to 12 h (1 h interval). 
Effect of seeding on native insulin aggregation was monitored by ThT fluorescence 
(Figure 3.26). The ThT fluorescence data for different timed seeds up to 4 h was fitted 
and analyzed by linear regression (Figure 3.23 to 3.25). The slope of the curves shows 
the kinetics of aggregation (Table 3.1). Aggregation kinetics of native insulin in the 
presence of 10-min seeds was maximum with a slope of 235.92±4.86 (Table 3.1); 
followed by seeds made by incubating insulin for 30 min and 4 h. Aggregation of native 
insulin in the presence of seeds prepared by incubating protein for 5 h or longer (up to 
12 h) had the slowest aggregation kinetics (Figure 3.25).  Therefore, these seeds were 
grouped into nascent (10 min), intermediate (30 min to 4 h) and mature (5 h to 12 h) 
seeds based on the difference in their aggregation kinetics (Table 3.1, Figure 3.23 to 
3.25).  
The rate of aggregation increases continuously in the presence of nascent seeds at a 
concentration of 5% and 15% v/v (Figure 3.18, 3.19). However at a concentration of 
45% (Figure 3.20), the aggregation rate is independent of “stage” of seeds (nascent, 
intermediate, or mature seeds) used to initiate aggregation. This maybe a result of 
saturation of the number of nucleation sites available for aggregation. This establishes 
the critical concentration of seeds necessary for proteins to aggregate in vitro and that 
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still shows a difference in aggregation kinetics. In summary, nascent seeds had the 
shortest lag time and fastest aggregation kinetics. This suggests that nascent seeds of 
insulin have high number of soluble misfolded proteins with exposed hydrophobic 
surface providing very high number of nucleation sites for native insulin to bind and 
aggregate compared to seeds prepared by longer incubation. The kinetics of 
aggregation was also observed to linearly depend on the seeding concentration in the 
presence of nascent seeds (Figure 3.27). This suggests that at higher seed concentration 
(e.g. 15% seed v/v) the number of available nucleation sites for seeds are more 
compared to seed concentration of 5% v/v and hence higher aggregation rate observed 
at higher concentration (Figure 3.27).  This is in line with another study that suggests 
partially-folded protein intermediates promote aggregation and not the mature 
aggregates35.  
Morphology of the aggregates formed as a result of seeding were characterized by 
atomic force microscopy (Figure 3.21, 3.22). The aggregates formed by native insulin 
incubated with nascent or intermediate seeds increased in size from 10 nm to 400 nm. 
Stiffness of aggregates as measured by Young’s modulus ranged between 4 ± 0.6 to 6 
± 0.2 GPa for the aggregates formed by nascent and intermediate seeds, which is 
comparable to values reported in literature61-64. These values suggest that the 
aggregates are relatively rigid and the high tensile strength of these aggregates maybe 
a result of strong hydrogen bonding as well as hydrophobic interactions contributing to 
the mechanical stiffness of the structure64, 65.  Interestingly, native insulin when 
incubated with intermediate seeds formed fibrils (Figure 3.21 B, C) that converted to 
amorphous aggregates upon longer incubation (24 h or more) (Figure 3.22). The 
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secondary structure of nascent and intermediate seeds along with native insulin 
(control) was investigated using FT-IR66, 67 to understand the morphological diversity 
of the seeds (Figure 3.28). A peak at 1656 cm-1 was observed for native insulin that is 
characteristic of α-helical proteins68-71. All the seeds show a peak at 1625 cm-1 that is 
characteristic of β-sheet structure. The raw spectra were deconvoluted and fitted using 
Gaussian function to obtain the major component peaks. Area under the deconvoluted 
peaks were integrated to calculate the percent contribution from α-helical or β-sheet 
structures, for each seeds. The α-helical content decreased with increase in incubation 
time. Nascent seeds (10 min) had nearly 63% of α-helical and 37% of β-sheet structures 
(Figure 3.28). This ratio changed to ~50% α-helical and ~50% β-sheet for intermediate 
seeds (4 h).  This suggests that the nascent seeds have significant native structure (α-
helix) that can contribute to native insulin aggregation in a nucleation dependent 
manner. In nascent seeds the α-helical structure acts as the site of nucleation for native 
insulin and the β-sheet component propagates the aggregation process in a template-
dependent manner. Intermediate seeds (30 min to 4 h) could also promote aggregation 
of native insulin due to the presence of significant α-helical structure (50% to 60%) 
present in them. AFM images of intermediate seeds incubated with native protein show 
formation of protofibrillar to fibrillar structures. This observation is complemented by 
FTIR data wherein increase in β-sheet structure is observed for both 1 and 4 h seeds. 
Kinetic data shows that 1 h seed is most efficient among intermediate seeds, in 
aggregating native insulin, which suggests that protofibrils are more efficient than 
fibrils in aggregating native insulin (Table 3.1, Figure 3.28).   Conversion of fibrils to 
amorphous aggregates within 24 h of incubation under our experimental conditions 
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shows the transient nature of these aggregates (Figure 3.29). This is in line with 
amorphous aggregates observed for disulfide-reduced insulin incubated at 37 °C for six 
months in this study.  Overall, this study and an earlier study shows that proteins under 
conditions that are reducing and close to physiological favor formation of amorphous 
aggregates57.  
 
 
 
Figure 3.29 Plausible aggregation mechanism model based on insulin aggregation in 
presence of different timed seeds. Nascent seeds promote rapid amorphous aggregate 
formation; intermediate seeds lead to formation of fibrillar structure in 4 h that converts 
to amorphous upon longer incubation of 24 h. Aggregation in the presence of mature 
seeds is very slow when compared to nascent and intermediate seed kinetics.  
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Conclusion 
In summary, this study measures the aggregation kinetics and characterizes the nature 
of aggregates of insulin formed under disulfide reducing conditions at pH 7.2 and 37 
°C. The results show that insulin aggregates rapidly under these conditions and forms 
amorphous aggregates that stay amorphous even upon incubation for six months. Seeds 
affect native insulin aggregation kinetics; with nascent seeds showing the fastest 
aggregation kinetics. Interestingly, incubation of native insulin with intermediate seeds 
for shorter period (4 h) results in fibril formation that converts to amorphous upon 
longer incubation (24 h).  These results suggest that insulin favors amorphous aggregate 
formation under disulfide reducing conditions at physiological pH and temperature.  
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Abstract 
Observation of protein aggregates in end stage tissues is hallmark of several 
neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer’s and 
Parkinson’s disease. However, the relationship between morphology of aggregated 
proteins and their associated toxicity is not clear. To better understand the relationship 
between distinct aggregated forms of proteins and their toxicity, we used insulin as a 
model protein. Morphologically distinct insulin aggregates were prepared by 
incubating the protein at various pH (2.0, 5.3, 7.0 and 8.8) and temperature (37 °C or 
65 °C) in presence or absence of disulfide reducing agent. The morphology and unique 
physic-chemical properties of the aggregates were characterized using spectroscopy 
and electron microscopy techniques. Insulin aggregates within 4 h in the presence of 
reducing agent at all pH studied. At acidic pH (pH 2.0 or pH 5.3) it forms rod-like 
aggregates at 37 °C and fibrils at 65 °C in absence of reducing agent. In the presence 
of reducing agent, insulin forms amorphous aggregates with distinct morphology at pH 
2.0 and 7.0. At pH 5.3 and 8.8, filamentous structures of varying lengths were observed. 
The cytotoxicity of these distinct aggregates were measured using human 
neuroblastoma (SH-SY5Y) cells. Overall, the results show that aggregates formed 
under disulfide reducing conditions at acidic pH were more toxic. 
 
 
 
 
 134 
 
Introduction 
Proteins are functional within a narrow range of temperature and pH, deviation from 
which leads to physical and/or chemical instability causing them to aggregate. 
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Parkinson’s and 
Alzheimer’s disease are a result of protein misfolding and aggregation1-4. However, the 
general mechanism by which these aggregates cause toxicity is not well understood. 
This is further complicated by the fact that there is no clear relationship between the 
morphology and toxicity of these aggregates. This diversity has been observed between 
different proteins as well as within mutants of the same protein5, 6. Majority of these 
disease causing proteins form β-sheet rich structures in vivo that are collectively known 
as amyloid fibrils, however structurally distinct fibrils have been observed in Aβ1-42  
and prion protein aggregates7, 8. These fibrils were also shown to possess diverse 
interaction patterns. Heterogeneous aggregate forms have also been observed in tissue-
derived aggregates of lysozyme, apolipoprotein and tau protein with disparate 
cytotoxicity7. Amyloid deposits have been occasionally found to contain alternate 
aggregate forms within amyloid plaques. These include Creutzfeld-Jacob disease, 
Down’s syndrome and rat model of Alzheimer’s disease 9-13. In vitro studies have also 
reported the formation of alternate aggregate forms in pathogenic Ig light chain, human 
serum albumin, lysozyme, β-lactoglobulin, insulin, and in solution of 40-residue Aβ-
peptide 14-21. Studies with Aβ protein have shown that the longer peptide (1-42) is more 
toxic to neuronal cells than Aβ1-40  and form amylospheroid like structures 22. Mature 
aggregate forms of Aβ1-42 exhibited high toxicity even at nano-molar concentrations 
when compared to immature oligomers23. Other disease related proteins such as 
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superoxide dismutase 1 (SOD1) also exhibit toxicity due to lack of copper and/or zinc 
in both wild type and mutant protein forms24. Although, a host of information is 
available on aggregate morphology and cytotoxicity from both in vitro and in vivo 
studies, yet the relationship between structure and toxicity of these aggregates is still a 
matter of debate. These observations suggest that the morphology of protein aggregates 
is highly dependent on aggregation conditions such as temperature, pH and other 
stresses in the cellular environment.  
To better understand role of misfolded proteins in the disease process, we need to 
characterize the structural changes in proteins due to change in pH, temperature, and 
external stresses and correlate aggregate morphology to its toxicity. The goal is to 
generate distinct aggregate forms from a single protein by manipulating the proteins 
local environment and test its toxicity. For this we chose a commonly studied model 
protein insulin as it can generate distinct aggregate forms. Insulin is an aggregation 
prone protein that forms fibrils at low pH and forms spherulites at elevated 
temperatures (65 – 75 oC) 18, 25-29, and amorphous aggregates near neutral pH under 
disulfide reducing conditions44. 
Insulin is a 51-residue protein consisting of two polypeptide chains A and B with 21 
and 30 residues respectively. There are two inter-chain disulfide bonds (A7-B7, A20-
B19) and one intra-chain disulfide bond  (A6-A11) that substantially constrain the 
structure and native fold of insulin30, 31. The intra-chain disulfide bonds are buried 
within the hydrophobic core of the protein.  Insulin aggregation has been studied 
extensively only at acidic pH due to ease of fibril formation, whereas fewer studies 
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have been done at physiological pH where amorphous aggregates and particulates are 
prevalent.32-37. Insulin stability is dictated by its conserved residues (Val A3, Ile A13 , 
Val B12 , Val B18 , Phe B24 , and Tyr B26) that are solvent exposed. At acidic pH, the net 
charge on these amino acid residues become positive owing to their isoelectric point 
ranging between 5 and 6, leading to destabilization of the native fold and subsequent 
aggregation38.  It is known that disulfide bridges are retained in the insulin fibrillation 
process and also the individual chains are capable of fibrillation that are structurally 
different from the intact insulin fibril39, 40. Partial reduction of disulfide bonds in the 
presence of tris(2-carboxyethyl)phosphine (TCEP) at low pH lead to the formation of 
flexible filaments of bovine insulin40. Toxicity of filaments formed from reduced 
bovine insulin at pH 1.6 is considerably lower than fibrils formed from insulin with 
intact disulfide bridges 40. Insulin oligomers and fibrils at acidic pH have been found to 
be toxic to PC-12 and SH-SY5Y cell lines41, 42. However, a systematic study on insulin 
aggregates formed at other pHs and temperature toxicity information of aggregates 
formed at different pH and temperature under disulfide reducing conditions is lacking. 
Hence it is important to understand the factors that trigger the formation of these 
alternate forms of aggregates, their morphology and the relationship to cytotoxicity. 
Having a better understanding of different aggregated forms of insulin and its 
relationship to cellular toxicity can help shed light on other protein aggregation diseases 
owing to the generic mechanism of protein aggregation 3.  
In this study, we prepared aggregates at acidic, neutral, and basic pH and also at the 
isoelectric point (pH 5.3)43 of insulin. Aggregation of insulin at pH above and below 
its isoelectric point is important for understanding the effect of net charge on the protein 
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and its contribution towards protein unfolding and subsequent aggregation. The 
aggregates were prepared by incubating insulin at physiological (37 oC) and elevated 
(65 oC) temperature to investigate the temperature dependence of aggregate 
morphology and aggregation kinetics. Disulfide bonds are central to protein stability 
and reduction of disulfide bonds can lead to aggregation in protein including 
insulin44,45. Therefore, to understand the effect of disulfide bond reduction on insulin 
aggregation and toxicity, we used 10 mM tris(2-carboxyethyl)phosphine (TCEP) – a 
non-thiol based reducing agent. Comparing and contrasting the distinct aggregate 
forms of insulin and their toxicity at different pHs, temperature, and oxidizing/reducing 
conditions will lead to a better understanding of the relationship between different 
aggregate forms and their toxicity.  
In this study, we demonstrate that insulin forms fibrils at acidic pH (2.0 and 5.3) but 
forms largely amorphous structures at basic pH (8.8), in the absence of TCEP. Insulin 
incubated without TCEP at pH 7 and 37 oC did not show any aggregation. In the 
presence of the reducing agent short, branched and long filaments were formed at pH 
5.3 and 8.8, respectively. Amorphous aggregate forms dominate at acidic and neutral 
pH. Comparison of the toxicity levels of the various aggregates show that insulin 
aggregates formed in the presence of reducing agent are more toxic to SH-SY5Y cells 
compared to non-reduced protein aggregates. We also observed that loose amorphous 
and globular aggregates formed at pH 2.0 are most toxic followed by the filamentous 
(short, branched and long) structures formed at the isoelectric point as well as basic pH, 
respectively. Interestingly, incubation temperature plays an important role in 
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accelerating the aggregation process, rather than altering the overall morphology and 
cytotoxicity of the aggregates. 
Materials and Methods 
Unless otherwise indicated, all materials were used as supplied by the manufacturer 
without any further purification. Human recombinant insulin, tris(2-
carboxyethyl)phosphine (TCEP), thioflavin T (ThT), 8-anilino-1-naphthalenesulfonic 
acid (ANS) dye, 4,4′-Dianilino-1,1′-binaphthyl-5,5′- disulfonic acid (Bis-ANS) dye 
were purchased from Sigma.  
Preparation of insulin samples - Insulin stock solutions were prepared as described 
earlier44. All insulin samples were prepared to a final concentration of 1 mg/mL in 20 
mM of respective buffers at pH 2.0 (Glycine-HCl), pH 5.3 and 8.8 (Tris-HCl), pH 7.0 
(HEPES), either in presence or absence of 10 mM tris(2 carboxyethyl)phosphine 
(TCEP).  The samples were prepared on ice followed by incubation both at 37 oC and 
65 oC for the indicated time periods (see figures for details). Blanks (contained 
everything except insulin) were similarly prepared and incubated as samples and were 
used for background subtraction.  
Intrinsic and extrinsic fluorescence- Fluorescence measurements were carried out 
using a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4). Excitation and emission 
slit widths were set at 2 nm, each. For intrinsic fluorescence, emission spectra were 
acquired from 285 to 450 nm with excitation at 280 nm. For extrinsic fluorescence, 
emission spectra were acquired in presence of 10 µM ThT, 5 µM ANS, or 1 µM Bis-
ANS. The concentrations of dye stocks were determined using their extinction 
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coefficients: ANS ε350 nm = 5000 M-1 cm-1, bis-ANS ε385 nm = 16790 M-1 cm-1, and ThT 
ε416 nm = 26,620 M-1 cm-1. Protein samples were diluted to a final concentration of 90 
µM using 20 mM of respective buffers for intrinsic, ANS and Bis-ANS fluorescence 
measurements. A final sample concentration of 30 and 15 μM were used for ThT 
fluorescence measurements. After timed incubation, diluted protein samples were 
equilibrated with respective fluorophores on ice, in dark for 30 min before acquiring 
the spectra. For ThT fluorescence, emission spectra were collected from 460 to 650 nm 
with excitation at 450 nm. Fluorescence spectra from 400 to 700 nm were collected 
with excitation at 380 nm for ANS and at 360 nm for bis-ANS. All measurements were 
done in triplicates.  
Fitting of ThT Fluorescence Data – ThT fluorescence data in the absence of reducing 
agent at pH 2.0 and 5.3 at 65 oC was fitted using a Gompertz function given by 𝑦𝑦(𝑡𝑡) =
𝐴𝐴. 𝑒𝑒−𝑒𝑒(𝑡𝑡−𝑡𝑡𝑖𝑖)𝑏𝑏  where 𝑡𝑡𝑖𝑖 is the lag time and b is the apparent aggregation rate 63. This 
function is used to fit sigmoidal growth/aggregation curves with relatively long lag 
times. 
Field Emission Scanning Electron Microscopy (FESEM) – Electron microscope 
images were collected using Hitachi S-4700 field-emission scanning electron 
microscope (FESEM). Samples incubated for indicated times were diluted 4-fold with 
MQ water and aliquoted in Millipore Amicon® Ultra centrifugal filters (3 kDa cut off). 
The diluted samples were centrifuged at 7000 x g at 4 oC (three repeats after dilution 
with water) to remove low molecular weight impurities (salt, buffer etc). The washed 
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samples were aliquoted on SEM stubs and air-dried. The samples were platinum coated 
using a sputter coater and imaged using an acceleration voltage of 5 kV. 
Cell Culture – Human neuroblastoma (SH-SY5Y) cells were maintained in DME/F12 
medium containing 10% fetal bovine serum, 100 U/mL penicillin and 100 μg/mL 
streptomycin in 5% CO2 at 37 oC.  
Toxicity Assay – Cell viability was determined using CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (MTS). It is based on the formation of formazan from 
tetrazolium salt by mitochondrial dehydrogenase. This reaction changes the color of 
viable cells to dark purple-blue and its absorbance is measured spectrophotometrically 
at 490 nm. The percentage of viable cells was determined using the absorbance of 
control cells as 100%.  
Insulin samples were washed with double-distilled water and diluted to a final 
concentration of 10 μM using cell-growth medium. Cells were plated in 96-well plates 
at a density of 15000 cells/well and grown overnight. The cells were then incubated 
with 100 μL of medium with and without insulin aggregates and incubated for 48 hours 
in 5% CO2 at 37 oC. Blanks containing insulin samples and medium were also 
incubated similarly, and used for background subtraction. After incubation, 20 μL of 
MTS reagent was added to each well and incubated for 4 hours at 37 oC, 5% CO2 
incubator. The absorbance of the cells was read using a micro-plate reader at 490 nm. 
All measurements were done in triplicates. 
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Figure 4.1 Ribbon structure of insulin (A) monomer at pH 2.0, (B) dimer at pH 5.3, 
and >8, and (C) hexamer at pH 7.0 showing the disulfide bonds (S−S, sand-yellow). 
The backbone is shown in gray color. The structures were generated using PyMOL 1.3 
and PDB files 1GUJ for monomer and 1AI0 for dimer and hexamer. 
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Figure 4.2 Protein misfolding and hydrophobic exposure monitored by ANS 
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to 
a final concentration of 90 μM and incubated with 5 μM ANS for 15 minutes before 
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at 
380 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission 
wavelength of 467 nm was selected. Peak fluorescence intensities are shown using open 
symbols (without TCEP) and closed symbols (10 mM TCEP). Data is representative of 
triplicates with error bars showing ± SD. 
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Figure 4.3 Protein misfolding and conformational tightening monitored by Bis-ANS 
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to 
a final concentration of 90 μM and incubated with 1 μM Bis-ANS for 15 minutes before 
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at 
360 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission 
wavelength of 482 nm was selected. Peak fluorescence intensities are shown using open 
symbols (without TCEP) and closed symbols (10 mM TCEP). Data is representative of 
triplicates with error bars showing ± SD. 
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Figure 4.4 Protein aggregation monitored by ThT fluorescence. Insulin samples 
incubated at a concentration of 172 μM were diluted to a final concentration of 90 μM 
and incubated with 10 μM ThT for 30 minutes before acquiring spectra. Emission 
spectra were collected from 460-650 nm with excitation at 450 nm for (A) pH 2.0 (B) 
pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission wavelength of 486 nm was 
selected. Peak fluorescence intensities are shown using open symbols (without TCEP) 
and closed symbols (10 mM TCEP). Data is representative of triplicates with error bars 
showing ± SD. 
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Figure 4.5 Protein misfolding and hydrophobic exposure monitored by ANS 
fluorescence. Insulin samples incubated at a concentration of 172 μM were diluted to 
a final concentration of 90 μM and incubated with 5 μM ANS for 15 minutes before 
acquiring spectra. Emission spectra were collected from 400-650 nm with excitation at 
380 nm for (A) pH 2.0 (B) pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission 
wavelength of 467 nm was selected. Peak fluorescence intensities are shown using open 
symbols (without TCEP) and closed symbols (1 mM TCEP). 
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Figure 4.6 Protein aggregation monitored by ThT fluorescence. Insulin samples 
incubated at a concentration of 172 μM were diluted to a final concentration of 90 μM 
and incubated with 10 μM ThT for 30 minutes before acquiring spectra. Emission 
spectra were collected from 460-650 nm with excitation at 450 nm for (A) pH 2.0 (B) 
pH 5.3 (C) pH 7.0 and (D) pH 8.8. Average peak emission wavelength of 486 nm was 
selected. Peak fluorescence intensities are shown using open symbols (without TCEP) 
and closed symbols (1 mM TCEP). 
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Figure 4.7 Rate of protein aggregation calculated using ThT fluorescence data. Insulin 
samples incubated at a concentration of 172 μM were diluted to a final concentration 
of 45 μM and incubated with ThT as detailed in Figure 4. Apparent rate of aggregation 
and lag time for (A) pH 2.0 and (B) pH 5.3 in the absence of TCEP at 65 oC were 
calculated after fitting the data to Gompertz growth function. The data points are 
experimental values fitted using the function. Data is representative of triplicates with 
error bars showing ± SD. 
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Figure 4.8 FE-SEM Images of insulin aggregates without TCEP.  One hundred seventy 
two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 4 h at pH 2.0 (A, E), 
pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all images. 
 
 
Figure 4.9 FE-SEM Images of insulin aggregates with 10 mM TCEP.  One hundred 
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 4 h at pH 
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all 
images 
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Figure 4.10 FE-SEM Images of insulin aggregates without TCEP.  One hundred 
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 72 h at pH 
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all 
images. 
 
 
Figure 4.11 FE-SEM Images of insulin aggregates with 10 mM TCEP.  One hundred 
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 72 h at pH 
2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for all 
images. 
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Figure 4.12 FE-SEM Images of insulin aggregates without TCEP.  One hundred 
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 7 days at 
pH 2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for 
all images. 
 
 
Figure 4.13 FE-SEM Images of insulin aggregates with 10 mM TCEP.  One hundred 
seventy two μM insulin was incubated at 37 oC (A-D) and 65 oC (E-H) for 7 days at 
pH 2.0 (A, E), pH 5.3 (B, F), pH 7.0 (C, G) and pH 8.8 (D, H). Scale bar is 1 μm for 
all images. 
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Figure 4.14 ThT emission spectra and SEM Images of insulin aggregates incubated for 
4 weeks. One hundred seventy two μM insulin was incubated at pH 2.0 (A), pH 5.3 
(B), pH 7.0 (C) and pH 8.8 (D) in the presence and absence of 10 mM TCEP at 37 and 
65 oC. Samples were diluted to a final concentration of 15 μM and incubated with 10 
μM ThT for 30 min on ice. Emission spectra was acquired from 460-650 nm after 
excitation at 450 nm. Insets show SEM images after 4 weeks of incubation for each pH 
in the absence (a, b; e, f; i, j; m, n) and presence (c, d; g, h; k, l; o, p) of 10 mM TCEP 
at 37 oC (a, c; e, g; i, k; m, o) and 65 oC (b, d; f, h; j, l; n, p). Scale bar is 5 μm for all 
images. Data is representative of average of triplicates. 
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Figure 4.15 Cytotoxicity effects of insulin aggregates by MTS assay. Aggregates were 
prepared by incubating 172 μM protein for 7 days, at all the indicated conditions and 
were diluted with cell growth medium. SH-SY5Y cells were plated in 96 well plates at 
a density of 15000 cells per well and grown overnight. Cells were then incubated in the 
absence (control) and presence of 10 μM insulin aggregates. Data is representative of 
triplicates with error bars showing ± SD. 
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Results & Discussion 
Insulin aggregation has been extensively studied and serves as a model protein for non-
neuropathic systemic amyloidosis and other amyloid diseases 47. Insulin is known to 
aggregate rapidly and form fibrils at acidic pH as well as in the presence of chaotropic 
agents such as urea, guanidine hydrochloride etc. 33, 35, 36, 39. Spherulite and filament 
formation of insulin has also been observed in in vitro studies at high temperatures and 
acidic pH 25-27. Few studies have also shown formation of amorphous aggregates of 
insulin at physiological conditions44. This suggests that insulin follows alternate 
aggregation pathways that are triggered by external conditions such as temperature, pH 
and oxidizing/reducing stresses, among others. The potential correlation between 
diverse aggregate forms to disease processes requires information about toxicity as 
well. Alternate aggregate forms of proteins such as spherulites and gels have been 
observed within amyloid plaques in certain diseases, although toxicity information of 
these aggregates are unknown12. Insulin fibrils and pre-fibrillar oligomers at acidic pH 
are known to be cytotoxic but toxicity details on alternate aggregate forms are 
unavailable 41, 42. Therefore we wanted to study the mechanism of aggregation of 
various forms of insulin aggregates, measure its associated kinetics, and understand the 
relation between aggregate structure and its cytotoxicity.  
We monitored insulin aggregation kinetics at pH 2.0, 5.3, 7.0 and 8.8 in the absence 
and presence of reducing agent (10 mM TCEP) at 37 and 65 oC using various 
spectroscopic techniques (Figures 4.2-4.7, 4.14). Morphology of various aggregate 
forms was characterized using SEM (Figures 4.8-4.13). Insulin forms morphologically 
diverse aggregates with distinct spectral properties in the absence and presence of 
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reducing agent. Cytotoxicity of the diverse aggregate forms was elucidated using 
human neuroblastoma SH-SY5Y cells (Figure 4.15). 
Insulin structure changes with change in pH. Zn-insulin shifts from monomer to its 
dimeric form at acidic pH with the equilibrium shifting towards the dimer with increase 
in pH. The protein is predominantly hexamer at neutral/physiological pH (Figure 4.1)34, 
48, 49. Beyond pH 7.4 insulin dissociates to form dimers due to loss of zinc binding that 
is facilitated directly by histidine at position B1050. These associations are 
predominantly dependent on the net charge on the protein and hence are dictated by the 
solution pH. 
Insulin aggregation and conformational change due to hydrophobic exposure was 
monitored using extrinsic fluorescent dye ANS (Figure 4.2). This dye is highly 
sensitive to its local environment and causes increase in fluorescence intensity and a 
corresponding blue shift when it binds to hydrophobic pockets of proteins. Quenching 
of fluorescence intensity and red shift is observed upon exposure to polar environment.  
Insulin incubated in the absence of TCEP at 37 oC did not show increase in fluorescence 
for the entire incubation period. However, with increase in incubation temperature to 
65 oC, fluorescence intensity does not increase up to 72 h and 7 days respectively for 
pH 2.0 and 5.3 (Figures 4.2A, 4.2B), beyond which fluorescence intensity increased 
very rapidly. Insulin exists as a monomer at acidic pH and it self-associates to form 
dimer near its isoelectric point. The monomer has two hydrophobic surfaces on each 
side that are capable of ANS binding and increase in fluorescence intensity. This is in 
line with the observation that fluorescence intensity rapidly increases after a lag time 
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of 72 h at pH 2.0, 65 oC. Dimerization of insulin with increase in pH, leads to burial of 
hydrophobic residues to some extent that is explained by the increase in lag time of 
aggregation from 72 h to 7 days in case of pH 5.3. Marginal increase in fluorescence is 
observed at neutral pH, however at basic pH it remained unaffected with increase in 
incubation temperature from 37 oC to 65 oC (Figures 4.2C, 4.2D). This suggests the 
absence of unfolding and exposure of hydrophobic residues at this pH due to presence 
of predominantly dimeric form of the protein at pH 8.8. Insulin aggregation at 37 oC 
was independent of the pH change, under our experimental conditions. This can be 
explained in light of previous studies that elevated temperature and/or other stresses 
are important to overcome the activation barrier in order to shift the equilibrium 
towards the unfolded state of the protein51. Earlier studies have shown that insulin 
aggregates at 37 oC within two weeks of incubation with continuous agitation 41.   
In the presence of reducing agent, ANS fluorescence of insulin (Figures 4.2A, 4.2B) 
showed a rapid increase for the first 4 h for all pH studied. Beyond 4 h fluorescence 
intensity decreased and steadied for both incubation temperatures, in case of pH 2.0 
and 5.3. At pH 7.0 and 8.8, decrease in fluorescence intensity beyond 4 h was 
continuous till the entire incubation time in case of 65 oC (Figures 4.2C, 4.2D). The 
amount of reducing agent used is enough to scramble the disulfide bonds of insulin. 
This causes unfolding and exposure of hydrophobic residues within 4 hours followed 
by hydrophobic collapse and burial that is marked by decrease in fluorescence intensity. 
Similar trends were observed in an earlier study with insulin at physiological pH and 
temperature 44.  
 156 
 
We used Bis-ANS, a dimeric analog of ANS to study the conformational flexibility of 
the insulin aggregates (Figure 4.3). Bis-ANS is known to fluoresce on binding to 
flexible molten-globule structures rather than highly rigid and hydrophobic structures. 
This property was used to assess the conformational tightening of insulin aggregates.  
Insulin in absence of reducing agent at 37 oC did not show significant change in 
fluorescence intensity over the 14 days incubation time. At 65 oC temperature, insulin 
in the absence of reducing agent showed fluorescence intensity increased rapidly within 
4 h followed by a gradual decrease in intensity, at pH 5.3, 7.0 and 8.8 (Figures 4.3B, 
4.3C, 4.3D). However, at pH 2.0 (Figure 4.3A), intensity dropped beyond 4 hours 
followed by gradual increase after 48 h of incubation time. This suggests that at pH 2.0 
and 5.3 newly formed aggregates (initial 4 h) are flexible that bind to Bis-ANS however 
with time the aggregates reorient themselves to form tighter conformations that is 
signified by the drop in fluorescence intensity past 4 h of incubation. For TCEP-treated 
insulin at both temperatures (37 and 65 oC) and all pH (2.0, 5.3, 7.0 and 8.8) bis-ANS 
fluorescence increased rapidly for 4 h followed by a gradual decrease signifying the 
formation of flexible aggregates that reorient to eventually form rigid structures leading 
to decrease in fluorescence. 
Morphology of insulin aggregates were monitored using ThT fluorescence (Figure 4.4, 
4.7) and further confirmed by scanning electron microscopy (Figures 4.8-4.13). ThT is 
classically known to bind to amyloid fibrils with a characteristic fluorescence. Insulin 
aggregates in oxidizing environment at 37 oC (all pH) did not show any fluorescence 
for the entire incubation time. This supports the ANS and bis-ANS fluorescence data 
confirming the non-existence of hydrophobic pockets or large aggregate forms at 
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physiological temperature incubation conditions. Electron micrographs confirm the 
fluorescence data finding. At acidic (2.0 and 5.3) and basic pH (8.8), insulin formed 
rod-like and amorphous aggregates respectively, without the characteristic 
fluorescence. This suggests the possibility that at physiological temperature, the cavity 
of aggregates formed is < 8 Å where ThT molecule could bind without inducing 
fluorescence 52. No aggregation was observed at neutral pH at 37 oC that is in line with 
an earlier study44.  
Insulin incubated at elevated temperature (65 oC) in the absence of reducing agent, 
show drastic increase in ThT fluorescence after 4h, 72 h and 7 days of incubation in 
case of pH 2.0 and 5.3 (Figure 4.4). The behavior is similar to that of ANS fluorescence 
(Figure 4.2) confirming that the aggregates formed at acidic pH is either fibrils or large 
structures with significant hydrophobic exposure. SEM images of the aggregates 
confirmed fibril formation for both pH conditions (Figures 4.8, 4.10, 4.12). 
Fluorescence intensity at pH 7.2 and 8.8 were almost half compared to acidic pH and 
the aggregates observed by SEM were amorphous. Earlier studies have shown that ThT 
can bind to large amorphous structures and the fluorescence is almost one-fifth to that 
of fibrils, in this case 52. Increased fluorescence intensity of amorphous aggregates of 
insulin at pH 8.8, as compared to the study by Yang et al. (2015) suggests at the 
aggregate cavity size is > 8 Å leading to increase in ThT fluorescence45. 
TCEP-treated insulin at both incubation temperatures follows similar trends. At pH 2.0, 
5.3 and 7.0, fluorescence intensity gradually increases for the 14 days incubation 
period, although at pH 8.8, ThT fluorescence decreases after 7 days of incubation. This 
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suggests that reduced insulin follows similar aggregation pattern that is more or less 
independent of the pH. The aggregate formation is slow with typically low cps counts 
that might be accounted by the small size of cavity of the ThT molecule to bind. 
Electron micrographs show amorphous aggregate formation in the presence of TCEP 
at pH 2.0 and 7.0 (both temperatures) whereas filamentous structures were observed at 
the isoelectric point and basic pH (Figures 4.9, 4.11, 4.13). An earlier study with TCEP 
induced bovine-insulin aggregation showed formation of filamentous aggregates at pH 
1.6 and high temperature, which is contrary to the observation under our experimental 
conditions 40. However, the authors found intact fibrils in the absence of TCEP that 
support our findings.  
We also wanted to understand whether decreasing the concentration of reducing agent 
decreased the kinetics of aggregation or altered the mechanism as well. We 
characterized insulin aggregates formed in the presence of 1 mM TCEP using ANS and 
ThT fluorescence (Figures 4.5, 4.6). We observed overall decrease in fluorescence 
intensity although the fluorescence trend remained unaltered, thereby confirming 
slower aggregation kinetics without altering the aggregation mechanism. 
The aggregation kinetics at pH 2.0 and 5.3 in the absence of TCEP at 65o C, followed 
a characteristic sigmoidal trend with a lag phase, growth phase and saturation phase of 
aggregate formation (Figure 4.7). Hence, ThT fluorescence data was fitted to a 
Gompertz growth function. This function provides the best fit to sigmoidal curves with 
long lag times and assumes first order reaction kinetics 53-56. The fitted function was 
used to calculate the lag time and apparent rate of aggregation in the fibrillation process 
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for both pH studied. At pH 2.0, insulin aggregated with a lag time of 137.7 h and 
apparent aggregation rate was 0.244 s-1. In case of pH 5.3, lag time and aggregate rate 
were 327.5 h and 0.052 s-1 respectively. This suggests that lag time of aggregation 
almost doubles with increase in pH with significantly slower rate (roughly one-fourth). 
The driving force of insulin aggregation is the acidic environment that leads to insulin 
monomer formation followed by rapid aggregation.  
Insulin formed diverse aggregate forms in oxidizing (0 mM TCEP) and reducing (10 
mM TCEP) environment when incubated for 4 h (Figures 4.8, 4.9). 72 h (Figures 4.10, 
4.11) and 7 days (Figures 4.12, 4.13). After 4 h of incubation, all the aggregate forms 
were amorphous. Morphology of the aggregates changed after 72 h incubation and they 
were similar to those observed after 7 days. In the absence of TCEP at physiological 
temperature, insulin formed rod-like structures at acidic pH (Figure 4.12 A, B) and 
amorphous aggregates at pH 8.8 (Figure 4.12 C). At neutral pH (Figure 10 D), no 
aggregation is observed. At elevated temperature, fibrillation is observed at pH 2.0 and 
5.3 (Figure 4.12 E, F), however fibril morphology is different at both pH. At neutral 
pH (Figure 4.10 G), aggregates formed are amorphous in nature whereas sponge-like 
amorphous aggregates are observed at basic pH (Figure 4.12 H). In the presence of 10 
mM TCEP, amorphous aggregates were observed at pH 2.0, 37 oC and at neutral pH 
for both incubation temperatures (Figure 4.13 A, C, G). However at 65 oC the 
aggregates were amorphous at pH 2.0 (Figure 4.13 E). At pH 5.3 and 8.8 insulin formed 
short, branched and long filaments, respectively at both physiological and elevated 
incubation temperatures (Figure 4.13 B, F, D, H). The stark difference in 4 h aggregates 
versus the later time points is also conspicuous from the ANS and Bis-ANS 
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fluorescence data. Increase in fluorescence (ANS, Bis-ANS) for the first 4 h of 
incubation suggests that these amorphous aggregates are transient and flexible that is 
formed by exposing the hydrophobic pockets. Gradual decrease of ANS, Bis-ANS 
fluorescence (Figures 4.2, 4.3) beyond 4 h, signifies reorientation and formation of 
stable, less flexible structures by hydrophobic collapse and burial. These observations 
also support earlier studies that amorphous aggregates convert into fibrils at low pH, 
high temperature and oxidizing environment.  
Insulin is known to form fibrils at low pH and high temperature. Previous studies have 
shown that long-term incubation of insulin converts amorphous aggregates in fibrils. 
In order to compare the effect of incubation temperature towards fibril formation, 
insulin was incubated for 4 weeks at 37 and 65 oC in the presence and absence of 10 
mM TCEP. The aggregates were characterized using ThT fluorescence and electron 
microscopy (Figure 4.14). Under reducing conditions at pH 2.0, insulin converted to 
filaments at 37 oC, and aggregate morphology did not change for 65 oC incubation 
temperature (Figures 4.14A – c, d). ThT fluorescence intensity for aggregates formed 
at both temperatures is comparable (Figure 4.14A). In the absence of TCEP, the rod-
like filamentous structures converted to fibrils at 37 oC with a significantly high ThT 
fluorescence.  Fibrils formed at 65 oC in 7-days converted into tightly wound fibrils 
after 4 weeks of incubation with ThT fluorescence intensity about ¼ to the fibrils at 
formed at physiological incubation temperature (Figures 4.14A – a, b). This can be 
explained in light of the structural differences between the fibrils formed at both 
temperatures. Fibrils formed after 4-weeks at 37 oC are loosely wound hence allowing 
space for ThT molecules to bind tightly and fluoresce. At 65 oC, the fibrils are tight and 
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twisted with minimal cavity for binding of ThT leading to low fluorescence and 
quantum yield. Kayed and coworkers observed thioflavin S negative results in human 
Alzheimer’s disease brain although it was fibril-positive using antibodies, confirming 
that thioflavin class of dye requires a specific binding cavity into the fibril in order to 
fluoresce 57. Our finding contradicts the evidence in literature that insulin forms fibrils 
at elevated temperature and low pH since we observed tight fibrils at 37 oC after 4 
weeks of incubation. This suggests that high temperature helps in accelerating the fibril 
formation and also affects the fibril packing and corresponding ThT fluorescence 
signal. 
In case of pH 5.3, 7.0 and 8.8, aggregate forms did not change significantly and are 
comparable to those observed after 7 days of incubation (Figures 4.12, 4.13). ThT 
fluorescence intensity increased significantly in case of samples incubated with and 
without 10 mM TCEP for at pH 5.3 (65 oC) (Figure 4.13 B) whereas fluorescence was 
maximum in case of reduced insulin for both pH 7.0 and 8.8 at 65 oC and 37 oC 
respectively (Figures 4.13 C, D). This suggests that ThT fluorescence is independent 
of aggregate morphology and largely depends on the size and nature of grooves 
available in the aggregate for ThT binding. Short filamentous and branched structures 
do not bind to ThT molecule leading to lower fluorescence intensity as observed in case 
of insulin aggregates without TCEP at pH 5.3. Similar trend is observed in case of pH 
8.8. In the absence of TCEP the aggregates are filamentous however, the larger 
amorphous aggregates contribute to maximum fluorescence intensity.  
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Insulin forms diverse aggregate forms when incubated at various pH and temperatures 
under reducing and non-reducing conditions. It is important to correlate aggregate 
morphology with its cytotoxicity in order to understand the stresses (pH, temperature, 
reducing agent) that contribute towards toxic aggregate formation. Insulin aggregates 
were formed by incubating the protein for 7 days at pH 2.0, 5.3, 7.0 and 8.8 at 37 and 
65 oC in the absence and presence of 10 mM TCEP. SH-SY5Y cells were incubated 
with insulin aggregates for 48 h and the toxicity of the aggregates were assessed using 
MTS assay. Aggregates formed due to scrambling of disulfide bonds at acidic pH, in 
the presence of reducing agent were significantly more cytotoxic compared to the 
aggregates with intact disulfide bonds. Reduction of disulfide bonds and possible 
formation of non-native disulfide bonds is the driving force towards aggregation in the 
presence of reducing agent. Scrambled disulfide bonds leads to instability of the 
protein, which could be a critical factor apart from the pH. Toxic behavior was majorly 
independent of incubation temperature. Maximum toxicity was observed for aggregates 
formed at pH 2 (loose amorphous aggregates) followed by pH 5.3 (short filamentous 
aggregates). This suggests that larger amorphous aggregates can be more toxic to cells 
since they can sequester the proteins that are critical for maintaining homeostasis in 
cells. Similar trend was observed in case of inclusion bodies in case of Huntingtin 
protein aggregation 58. Longer fibrils/filaments and smaller amorphous aggregates (pH 
8.8) are less cytotoxic when compared to shorter filaments since the latter can enter 
cells owing to its small size and disrupt cellular functions. Insulin aggregates formed 
at physiological and basic pH exhibited maximum cell viability compared to those at 
acidic pH. This suggests the insulin aggregates at acidic pH, disrupt cellular function 
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and confer toxicity in a multitude of ways, however reduced disulfide bonds add to the 
toxic nature of the aggregates (Figure 4.16).  
 
 
Figure 4.16 Plausible model of pH-dependent insulin aggregation and toxicity. Insulin 
aggregates at pH 2.0 and 5.3 are relatively more toxic to SH-SY5Y cells, than those at 
pH 7.0 and 8.8. Scrambling of disulfide bonds lead to increase in toxicity at acidic pH. 
Cytotoxicity at neutral/basic pH is comparable for both oxidized and reduced forms of 
the protein. Surface charge is shown on protein at respective pH using Adaptive 
Poisson-Boltzmann Solver (ABPS) Software 59. 
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Conclusion 
In summary, this study monitors the kinetics and mechanism of insulin aggregation 
under various external stresses in the form of pH, temperature and reducing 
environment. Insulin aggregates in the presence of reducing agent within 4 h of 
incubation at both physiological (37 oC) and elevated (65 oC) temperatures, at all pH 
studied. In oxidizing environment, insulin aggregation kinetics and morphology is both 
pH and temperature dependent. Morphology of insulin aggregates were diverse and 
distinct ranging from amorphous, fibrils to filamentous structures. Aggregates formed 
in the presence of reducing agent at acidic environment were more toxic to human 
neuroblastoma (SH-SY5Y) cells compared to those formed in the absence of reducing 
agent, suggesting that pH and disulfide bond status play an important role in toxicity 
of the aggregated forms.  
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Abstract 
Misfolding and aggregation of proteins have been associated with various 
neurodegenerative diseases. While we have intensely focused on understanding the 
factors that govern misfolding and aggregation of proteins in vitro; not enough focus 
has been devoted to understanding how molecular crowding may impact the process.  
It is important to mimic the protein-misfolding scenario within the crowded cellular 
environment. Therefore, we have used macromolecular crowding agent polyethylene 
glycol (PEG) to mimic molecular crowding in cells. 
The main aim of this study is to understand the effect of macromolecular crowding 
agent PEG on lysozyme stability and aggregation in the presence of thermal and 
reducing environment stress. We investigated lysozyme unfolding between 25-95 oC 
using temperature dependent intrinsic and ANS fluorescence spectroscopy in the 
presence of both thiol and non-thiol based reducing agents dithiothreitol (DTT) and 
tris-(2-carboxyethyl) phosphine (TCEP). Varying concentrations of PEG-600 and 
PEG-2000 were used as molecular crowding crowding agents. 200 mM of PEG-2000 
exhibited stabilizing effect towards lysozyme in the presence of TCEP whereas PEG 
had no effect in the presence of DTT, irrespective of the molecular weight used in the 
study.  
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Introduction 
Protein misfolding and aggregation have been linked to several neurodegenerative 
disorders and amyloid diseases1. Protein aggregates are majorly found as deposits 
within the brain, liver, spleen and heart2. These aggregated forms have been generated 
in many in vitro studies using both physiological and non-physiological conditions to 
understand the mechanism of the disease process. These studies are carried out in dilute 
environment, which is significantly different than the cellular environment. The interior 
of all cells contains high concentration of macromolecules (proteins, polysaccharides, 
lipids) that occupy approximately 30% of the cell volume. These macromolecules lead 
to volume exclusion causing significant thermodynamic and kinetic consequences on 
the properties of other molecules present in the cell3. Volume exclusion effect leads to 
specific and non-specific interactions within the cell leading to 
perturbations/alterations in the biochemical processes within the cell. Crowding is 
known to favor formation of macromolecular complex and the compact conformations 
of proteins as opposed to its unfolded state4. Hence, it is important to investigate the 
mechanism of protein folding and aggregation in a crowded environment in order to 
understand the disease process. 
Lysozyme is a widely studied model protein due to its rich phase behavior that includes 
crystallization, liquid-liquid phase separation and formation of equilibrium 
clusters/gels5.  The biophysical characteristics of this 14.7 kDa globular protein has 
been extensively studied by measuring the average properties of the conformational 
isomers that exist at thermodynamic equilibrium in denatured lysozyme6. Studies with 
lysozyme have shown that high concentrations of crowding agent (200 g/L) did not 
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affect refolding of oxidized lysozyme but disrupted the refolding of protein. Denatured 
lysozyme with intact disulfide bonds can be renatured efficiently by rapid dilution 
whereas renaturation of the reduced protein by dilution is inefficient unless the protein 
concentration is significantly low. Two-state unfolding mechanism of lysozyme was 
studied using disulfide-scrambled lysozyme7. However, very little is known how 
molecular crowding agents impact lysozyme stability and aggregation in the presence 
of disulfide reducing agents. The general mechanism of protein misfolding and 
aggregation of disulfide reduced protein is by scrambling of disulfide bonds8, 9. Hence, 
it is important to understand how crowding agents can impact protein aggregation 
under reducing conditions. For this we used lysozyme as a model protein as its 
aggregation properties in dilute solutions have been extensively studied6, 7. 
A large number of molecules are known to provide volume exclusion effect in in vitro 
studies10. At high concentrations, these molecules preferentially hydrate the protein 
surface, thereby favoring the compact state of the protein11. These molecules include 
amino acids, salts, sugars and polymers like polyethylene glycols (PEG). The 
mechanism of action in case of most amino acids, sugar and salt is through cohesive 
force of water that is known to stabilize the native structure of the protein. However, 
PEG is known to exhibit both stabilizing and destabilizing effects on the protein12. 
Multiple theories have been proposed to explain the mechanism of action of PEG on 
protein13. Preferential hydration in the presence of the polymer has been hypothesized 
to be due to steric exclusion as well as charge on the protein14. Steric exclusion arises 
due to the difference in size of the water molecule and that of the additives/crowding 
agents. The large size of crowding agents such as PEG is key in its exclusion from the 
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protein surface by steric exclusion mechanism11. The effect of PEG on protein thermal 
stability has been shown to be molecular weight and concentration dependent15. 
However, how does PEG impact stability of disulfide reduced proteins has not been 
studied. 
The main aim of this study is to investigate the thermal unfolding of lysozyme in the 
presence of PEG and disulfide reducing agents dithiothreitol (DTT) and tris (2-
carboxyethyl) phosphine (TCEP). DTT is a thiol based reducing agent unlike TCEP. 
Thermal unfolding of lysozyme was monitored between 25 oC to 95 oC in the presence 
of varying concentration of reducing agents and PEG in order to understand the effect 
of concentration on thermal unfolding of lysozyme. Effect of molecular weight of PEG 
on lysozyme unfolding was also studied using a low (600 g/mol) and medium (2000 
g/mol) molecular weight of the polymer.  
Materials and Methods 
Unless otherwise indicated, all materials were used as supplied by the manufacturer 
without any further purification. TCEP was purchased from Thermo Scientific Pierce; 
lysozyme, DTT, 8-anilino-1-naphthalenesulfonic acid (ANS) dye, PEG-600 and PEG-
2000 were purchased from Sigma.  
Preparation of Lysozyme Samples - Lysozyme stock was freshly prepared by 
dissolving the lyophilized protein in 20 mM 4-(2 hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer at pH 7.0. Lysozyme concentration was 
determined using UV-Visible spectroscopy using extinction coefficient ɛ280 nm = 38940 
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M-1 cm-1. Working protein solution contained 40 μM protein in 20 mM HEPES buffer 
at pH 7.0.  
Sample Preparation and Heat Treatments - Samples were prepared by incubating 
lysozyme with varying concentrations of reducing agents DTT (2 and 5 mM) and TCEP 
(0.5 and 1 mM), along with 20 and 200 mM of PEG-600 and PEG-2000. Respective 
controls without PEG and reducing agents were also incubated.  
For heat treatment, each sample was heated to a fixed temperature (25-95 oC, 5oC 
intervals) for exactly 12.5 min and cooled on ice for 10 min16. 
Intrinsic and extrinsic fluorescence spectroscopy - Fluorescence measurements were 
carried out on a Horiba Jobin Yvon spectrofluorometer (Fluoromax-4) at room 
temperature. Slit widths of 2 nm (entrance and exit) were used for all measurements. 
After heat treatments, intrinsic fluorescence spectra of the samples were collected in 
the 285-450 nm range after exciting at 280 nm.  
For extrinsic fluorescence measurements, heat treated samples were incubated with 5 
μM ANS dye for 15 min on ice. ANS stock solution was prepared in 100% ethanol. 
Concentration of the dye was determined using extinction coefficient ɛ350 nm = 5000 M-
1 cm-1. Fluorescence spectra were collected between 400-650 nm after excitation at 380 
nm.  
Reducing and Non-Reducing Gel Electrophoresis - Heat treated protein samples 
(40uM) at 50 oC and 95 oC were mixed with fresh prepared 100 mM iodoacetamide 
(IAA) and incubated at room temperature for 2 hours to facilitate the blocking of free 
thiol groups.  The reaction was terminated by adding sodium dodecyl sulfate (SDS) 
sample buffer containing no reducing agents and boiled for 3 minutes. The reduced 
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protein samples were prepared by adding SDS sample buffer containing 5% β-
mercaptoethanol to protein samples (40uM) and was boiled for 3 minutes.  All samples 
(10 μg/lane) were run on 15% Tris-HCl polyacrylamide gel using Tris-glycine-SDS 
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) for 3.5 hours at 80 
V. The gels were stained using Coomassie blue stain and image was acquired using a 
scanner.  
Field-Emission Scanning Electron Microscopy (FESEM) - Samples were prepared as 
described earlier. Briefly, heat treated samples were washed with MQ water and 
aliquoted on SEM stubs and dried at room temperature. The samples were coated with 
10 nm platinum using a sputter coater. Images were acquired using an acceleration 
voltage of 10 kV.  
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Results & Discussion 
Lysozyme is a small globular protein with 4 disulfide bonds at positions C6-C127, C30-
C115, C64-C80 and C76-C9417. It is majorly α-helical protein with some β-sheet 
structure and a loop. The disulfide bridge between C6-C127 connects the N- and C-
terminal of the protein and is partially solvent accessible, whereas other disulfide bonds 
are buried into the hydrophobic pocket of the protein. Under reducing conditions, 
lysozyme unfolds leading to formation of a random-coiled polypeptide. The protein 
exhibits two-stage thermal denaturation in the presence of chaotropic agents, thus 
serving as a model protein for studying thermal unfolding and effect of macromolecular 
crowding7. However, the denaturation process of lysozyme in the presence of reducing 
agent and macromolecular crowding agent in combination with thermal stress is 
unknown. Hence it is important to understand the unfolding of lysozyme with thermal 
stress in the presence of both thiol and non-thiol based reducing agents DTT and TCEP 
respectively. The mechanism of action of both reducing agents is distinct and it is 
important to investigate their effect on lysozyme denaturation in a macromolecular 
crowding environment18.  
We monitored thermal unfolding of lysozyme between 25 to 95 oC in the presence of 
20 and 200 mM of both PEG-600 and PEG-2000. Disulfide bond reduction of lysozyme 
was carried out using varying concentrations of both thiol and non-thiol based reducing 
agents DTT (2, 5 mM) and TCEP (0.5, 1 mM), respectively. Thermal unfolding of the 
protein was monitored using intrinsic fluorescence spectroscopy (Figures 5.1, 5.2)14, 17. 
Conformational change and hydrophobicity was measured using ANS fluorescence 
(Figures 5.3, 5.4). Reducing gel electrophoresis (SDS-PAGE) was used to determine 
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whether the protein was completely reduced due to the heat treatment (Figure 5.5). 
Morphology of the aggregates in the presence of disulfide reducing agents and PEG 
was monitored using scanning electron microscopy (FESEM) (Figure 5.6). 
Lysozyme like other proteins, contain tryptophan residues that absorb UV radiation 
and can be excited. The electronic transition back to the ground state is associated with 
photon emission observed as intrinsic fluorescence. This signal quenched in aqueous 
environment19. Unfolding of lysozyme due to thermal stress in the presence of TCEP 
and DTT was monitored. In the absence of TCEP and DTT, intrinsic fluorescence is 
not observed even in the absence and presence of 20 and 200 mM (Figures 5.1, 5.2). In 
the presence of 0.5 and 1 mM TCEP, intrinsic fluorescence in observed in the presence 
of PEG (Figure 5.1). Earlier studies have shown the tryptophan fluorescence of proteins 
get affected in the presence of PEG. Fluorescence is not observed in case of native 
proteins, which is in line with our observation of no fluorescence intensity in the 
absence of TCEP. However, PEG is known to bind to the molten globule form of 
proteins20. Presence of 0.5 and 1 mM TCEP can partially unfold lysozyme, leading to 
the formation of molten globule structure, thus facilitating PEG binding with lysozyme 
and hence increases fluorescence20. In the presence of 200 mM PEG-600 and PEG-
2000 fluorescence intensity decreases suggesting stabilization of the protein structure 
by PEG binding. Previous studies have shown that PEG bound to protein can either be 
stabilizing or destabilizing depending on the size of PEG10. We observe similar trend 
where PEG-600 does not have any significant stabilizing effect whereas the higher 
molecular weight form of PEG has a greater stabilizing effect on the protein.   
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In the presence of both 2 and 5 mM DTT, intrinsic fluorescence is observed for both 
PEG-600 and PEG-2000 (Figure 5.2). This suggests that the mechanism of disulfide 
reduction plays an important role in the thermal unfolding of lysozyme. DTT reduced 
disulfide bonds are known to oxidize with time and form non-native disulfide bridges, 
whereas reduction of disulfide bonds is an irreversible process in the presence of non-
thiol based reducing agent TCEP18. This is in line with an earlier study where authors 
observed that thiol based reducing agent inhibited lysozyme refolding in the presence 
of guanidine hydrochloride, whereas the oxidized form of the protein refolded.  
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Figure 5.1. Effect of PEG on the thermal unfolding of lysozyme in the presence of 
TCEP, monitored by intrinsic fluorescence spectroscopy. Fluorescence spectra of 
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the 
presence of (A) 0.5 mM TCEP, PEG-600 (B) 0.5 mM TCEP, PEG-2000 (C) 1 mM 
TCEP, PEG-600 and (D) 1 mM TCEP, PEG-2000. Samples were excited at 280 nm 
and emission spectra were collected between 285-450 nm. Peak wavelength of 365 nm 
was chosen based on the difference spectra. 
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Figure 5.2. Effect of PEG on the thermal unfolding of lysozyme in the presence of 
DTT, monitored by intrinsic fluorescence spectroscopy. Fluorescence spectra of 
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the 
presence of (A) 2 mM DTT, PEG-600 (B) 2 mM DTT, PEG-2000 (C) 5 mM DTT, 
PEG-600 and (D) 5 mM DTT, PEG-2000. Samples were excited at 280 nm and 
emission spectra was collected between 285-450 nm. Peak wavelength of 365 nm was 
chosen based on the difference spectra.  
 
Exposure of hydrophobic pockets due to thermal unfolding of lysozyme was monitored 
using ANS dye (Figures 5.3, 5.4). Presence of PEG-600 did not affect the 
hydrophobicity of lysozyme when compared with samples with PEG and 0.5 mM 
TCEP (Figure 5.3 A). However, 200 mM of PEG-2000, lead to decrease in ANS 
fluorescence in the presence of 0.5 mM TCEP signifying decreased hydrophobicity. 
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Significant decrease in hydrophobicity and consecutive ANS fluorescence was 
observed in the presence of 1 mM TCEP and 200 mM PEG-2000 (Figure 5.3 C) 
whereas subtle decrease in fluorescence was observed with PEG-600 and 1 mM TCEP 
(Figure 5.3 D). Control groups without TCEP and increasing concentrations of PEG-
600 and PEG-2000 did not show any fluorescence due to lack of protein unfolding and 
exposure of hydrophobic pockets. This is in line with the intrinsic fluorescence data 
where significant lysozyme stabilization was observed in the presence of 1 mM TCEP 
and 200 mM PEG-2000.  
ANS fluorescence results with DTT are in line with intrinsic fluorescence and no 
change is observed in the presence of PEG with 2 and 5 mM DTT.  
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Figure 5.3. Effect of PEG on the hydrophobicity of lysozyme in the presence of 
TCEP, monitored by ANS fluorescence spectroscopy. Fluorescence spectra of 
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the 
presence of (A) 0.5 mM TCEP, PEG-600 (B) 0.5 mM TCEP, PEG-2000 (C) 1 mM 
TCEP, PEG-600 and (D) 1 mM TCEP, PEG-2000. Samples were excited at 380 nm 
and emission spectra was collected between 400-650 nm. Peak wavelength of 365 nm 
was chosen based on the difference spectra.  
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Figure 5.4. Effect of PEG on the thermal unfolding of lysozyme in the presence of 
DTT, monitored by ANS fluorescence spectroscopy. Fluorescence spectra of 
thermal unfolding of 40 μM lysozyme from 25 oC to 95 oC was measured in the 
presence of (A) 2 mM DTT, PEG-600 (B) 2 mM DTT, PEG-2000 (C) 5 mM DTT, 
PEG-600 and (D) 5 mM DTT, PEG-2000. Samples were excited at 380 nm and 
emission spectra were collected between 400-650 nm. Peak wavelength of 365 nm was 
chosen based on the difference spectra.  
 
 
Non-reducing SDS PAGE of heat-treated samples at 50 oC and 95 oC show formation 
of dimeric species at 50 oC in the presence of 1 mM TCEP whereas at 95 oC, dimers 
are visible in the presence of DTT only (Figure 5.5). This suggests the protective role 
of 1 mM TCEP towards lysozyme aggregation as the protein unfolds due to increase in 
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heat treatment temperature. In line with fluorescence study, lysozyme aggregates in the 
presence of DTT and PEG does not affect the aggregation process.  
Morphology of heat-treated lysozyme samples was visualized using scanning electron 
microscope. Lysozyme samples that were exposed to 50 oC did not show any aggregate 
formation under the microscope (data not shown). However, a higher molecular weight 
(28 kDa) is visible in the non-reducing gel. This suggests the formation of lysozyme 
dimer due to intermolecular interaction but not visible aggregates under the scanning 
electron microscope. Samples heat-treated to 95 oC show amorphous aggregate 
formation both in the presence of TCEP and DTT.  
 
 
Figure 5.5.  SDS Gel Electrophoresis of heat-treated lysozyme samples. Lysozyme 
(10 μg/lane) was loaded on 15% gel. The gels were run for 3.5 hours at 80 V followed 
by staining with Coomassie blue stain. Reducing SDS-PAGE was run for heated treated 
lysozyme at (A) 50 oC and (B) 95 oC. Samples were reduced using 5% β-
mercaptoethanol and boiled for 3 minutes. High molecular weight species were 
visualized using non-reducing SDS-PAGE for heat-treated lysozyme at (C) 50 oC and 
(D) 95 oC, after blocking the free sulfhydryl groups with 100 mM iodoacetamide.  
 189 
 
 
Figure 5.6. Scanning electron micrographs of lysozyme aggregates. Heat-treated 
lysozyme samples were imaged using SEM. Lysozyme was heat treated at 95 oC with 
(A) 1 mM TCEP, 200 mM PEG-600 (B) 1 mM TCEP, 200 mM PEG-2000 (C) 2 mM 
DTT, 200 mM PEG-600 (D) 2 mM DTT, 200 mM PEG-2000 
 
Conclusion 
In summary, the role of macromolecular crowding agent PEG in lysozyme unfolding 
was investigated. The protein was exposed to a range of thermal stress between 25 to 
95 oC, in the presence of thiol and non-thiol based reducing agents DTT and TCEP 
respectively. In the presence of TCEP, lower concentrations of PEG-600 and PEG-
2000 (20 mM) did not have any effect on lysozyme, however 200 mM of PEG had a 
stabilizing effect on the protein. Stabilization was monitored using temperature-
dependent intrinsic and extrinsic fluorescence and it was directly related to the 
molecular weight of the macromolecular crowding agent. Lysozyme in the presence of 
DTT did not have any effect of PEG and aggregation of the protein was observed at 
higher temperatures. This suggests that the mechanism of action of the reducing agent 
plays an important role towards the efficacy of PEG in stabilizing the native structure 
of lysozyme. 
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Chapter 6. Conclusion and Future Directions 
 
The broad aim of this work is to investigate the aggregation kinetics, mechanism and 
morphology of model protein insulin, in the presence and absence of disulfide-reducing 
agents and its relation to cellular toxicity. Elucidating protein aggregation mechanism 
and its implications for cellular toxicity is important in order to understand 
neurodegenerative disease process that are primarily due to protein misfolding.  
The main aim of the first project was to investigate the aggregation kinetics and 
mechanism of insulin in the presence of dithiothreitol (DTT) – a thiol based reducing 
agent, using various spectroscopic techniques (Chapter 3). Morphology of the 
aggregates were characterized using scanning electron microscope. Nucleation 
dependent aggregation of insulin in the presence of preformed seeds were monitored 
using fluorescence spectroscopy and atomic force microscopy. Insulin formed 
amorphous aggregates in the absence of seeds whereas in the presence of seeds, 
transient fibril formation was observed that converted to amorphous forms within 24 
hours.  
Based on the findings from the first project, subsequent work involved correlation of 
insulin aggregates with their cytotoxicity using human neuroblastoma (SH-SY5Y) cells 
(Chapter 4). Diverse forms of insulin aggregates were prepared in the presence and 
absence of tris (2-carboxyethyl) phosphine (TCEP) – a non-thiol based reducing agent, 
using a variety of pH and temperature conditions. Insulin aggregates were prepared at 
acidic, neutral and basic pH at physiological (37 oC) and elevated (65 oC) temperature. 
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Cell viability in the presence of insulin aggregates with reduced disulfide bonds were 
much lower compared to their oxidized counterpart suggesting the importance of 
disulfide bonds in native protein fold. 
The objective behind studying protein aggregation kinetics and its mechanism is to 
identify factors that influence protein aggregation. The goal is to characterize these 
distinct aggregate forms from the same protein under different condition and to identify 
the toxic fold/shape.  
As cellular environment is highly crowded we wanted to understand how these 
destabilizing factors (disulfide reducing conditions, temperature) can influence protein 
stability and aggregation. Macromolecular crowding agents have been known to 
stabilize proteins against thermal stresses and against denaturants. The third part of the 
work involves understanding the protective role of a crowding agent polyethylene 
glycol (PEG) against lysozyme aggregation in the presence of thermal and reducing 
stress (Chapter 5). The role of concentration and molecular weight of PEG towards 
lysozyme aggregation at a range of temperature (25-95 oC) and reducing stress was 
studied. PEG was found to prevent lysozyme aggregation in a molecular weight and 
concentration dependent manner.  
The mechanism of protein aggregation in neurodegenerative diseases has been shown 
to be generic in nature. Hence, information obtained from study of model proteins can 
be extrapolated to disease causing proteins such as TAR DNA binding protein (TDP-
43), Amyloid-beta protein (Aβ-42), Superoxide dismutase 1 (SOD1) etc. 
Characterizing various aggregate forms of model proteins, and correlating these 
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aggregates to their toxicity is important in order to understand neurodegenerative 
disease process. However, the scarcity of information about the disease related proteins 
increase the complexity. So, it will be important to study other model proteins and also 
characterize disease related proteins under similar experimental conditions in order to 
understand how protein misfolding and aggregation leads to these late onset 
neurodegenerative diseases. 
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